CORONA Main Coronavirus thread

psychgirl

Has No Life - Lives on TB
(fair use applies)

Novavax vaccine contains 1 mcg of insect (the fall armyworm) and baculovirus proteins and a bit of their DNA too, which is injected into you with each dose
And that's before we consider the Matrix-M novel adjuvant it contains
Meryl Nass
13 hr ago

You see, the vaccine’s spike protein is grown by genetically engineering baculoviruses to produce spike, and then infecting insect cells with the baculovirus to turn the whole thing into a spike protein factory.

At the CDC’s Advisory Committee on Immunization Practices meeting that I live-blogged last week, it was revealed that the Novavax vaccine was being rolled out because it could be marketed as a “more traditional” vaccine, since it was not made from mRNA. Novavax was to be directed to the unvaccinated, although only 10% of the unvaccinated, it was anticipated, would accept it.

The fact that no fetal cells were used in its development was claimed to be a marketing plus. However, thanks to a reader, it turns out that a human fetal cell line, (HEK) 293F, was used in the testing of the vaccine, as described in an article in Science.

NOTHING about this vaccine is traditional.

First, the Novavax company does not own a manufacturing plant, so the vaccine being distributed in the US is made at the Serum Institute of India.

Second, the adjuvant, Matrix-M (a nonspecific, potent immune stimulant) has never been used before. It is made from the Quillaja saponaria tree. There is another adjuvant that is only used in one (highly reactogenic) US vaccine, Shingrix, which is an extract from this tree. This GSK adjuvant, named ASO1B, contains QS-21, a single extract in the Shingrix vaccine.

The problem is that we don’t know what extracts from the tree are included in Matrix-M. The information is proprietary!
The Matrix-M adjuvant uses two unspecified “fractions” from the Q. saponaria tree, and there exist no data on its safety. (Matrix-M does not contain QS-21, although the company sometimes implies it does, to distract from its novelty.) These two fractions, combined with phospholipids and cholesterol, form the 40 nanometer particles of Matrix M.



While the tree extracts are potent immune stimulants, all those characterized also have significant toxicity.

Third, in addition to getting 5 mcg of spike protein in every dose, you will receive 1 mcg of residual amounts of baculovirus and Sf9 cell proteins (≤ 0.96 mcg), and baculovirus and cellular [from the fall armyworm] DNA (≤ 0.00016 mcg), according to the FDA.

So, you are getting an additional 20% protein of insect and baculovirus origin in addition to the 5 mcg of spike protein, in each of your two doses.


The fall armyworm

In other words, the Novavax vaccine is not sufficiently purified. And no one can tell you how the insect and viral protein and DNA contaminants will affect you.

Anyone who tells you that the Novavax vaccine is a traditional protein vaccine is a scoundrel. This vaccine is another "bait and switch" being rolled out solely to entice the unvaccinated, because it is not made of mRNA.

* But it still gives you a big dose of the spike poison.

There is a single other vaccine in the US that uses the fall armyworm-baculovirus platform to produce viral proteins. It is one of about a dozen available flu shots, whose brand name is Flublok. It too contains worm and viral DNA and protein.
See item 11 in its label.

Fourth, the regulators admit they have no idea if the vaccine works nor how dangerous it is. See below, which is a screenshot I took from the ACIP advisory committee meeting on Novavax.

It makes clear that the regulators don’t know how much myocarditis the Novavax causes, nor whether it works against current variants.

But they still want you injected. See the last line: it will be important to figure out if it works or is safe after authorization. Your tax dollars at work. But the vaccine is "free."

Will you be fooled again?

Welp, theres some of MY questions answered.
How depressing.
I was truly, hoping for something I can trust.

(Thank you for all the work and posting done here last night! I’m trying to get caught up)
 

Zoner

Veteran Member
This looks premeditated
In a concise new video (3:30), Dr Bhakti explains that the so-called “vaccines” are “agents that have no benefit whatsoever… but have the capacity over a million pathways to kill you… This looks premeditated.” (March 2022)

 

psychgirl

Has No Life - Lives on TB
This looks premeditated
In a concise new video (3:30), Dr Bhakti explains that the so-called “vaccines” are “agents that have no benefit whatsoever… but have the capacity over a million pathways to kill you… This looks premeditated.” (March 2022)

Wow.
 

Red Baron

Paleo-Conservative
_______________
Fair Use Cited
---------------

Houston physician files $25M defamation lawsuit against Houston Methodist Hospital

Re'Chelle Turner, Reporter, Houston
Published: July 24, 2022 at 10:17 PM
Updated: July 25, 2022 at 11:57 AM

HOUSTON – A physician who had her privileges suspended from Houston Methodist Hospital has filed a massive lawsuit.
Dr. Mary Bowden is seeking $25 million dollars after she says the hospital ‘defamed’ her.

In a 19-page lawsuit, Bowden says Houston Methodist Hospital damaged her reputation and published defamatory statements to the press and on social media. She hopes the lawsuit will make it safer for others to speak out.

“The way they came after me was unprofessional, unprecedented against the spirit of bylaws of their bylaws,” Bowden said.

In November, Dr. Bowden resigned from the hospital after her privileges were suspended because of her views on vaccines and early treatment for COVID-19.

“I was proud to get privileges there. It’s very sad what they have become,” she said.

The ENT doctor who runs her own private practice and says she has treated over 4,000 patients with COVID-19 will be filing a $25,000,000 defamation lawsuit against Methodist Hospital.”

“Tried my best to help the people that needed help and Methodist came out against me in a very public and vicious way. They implied that I was dangerous which as a physician leaves a permanent scar on your record, on your reputation,” Bowden said.

Bowden began sharing her opinions on Twitter, including her view that vaccine mandates are wrong, and says Methodist retaliated against her in an unprecedented manner.

The lawsuit refers to a series of tweets from Houston Methodist that say Dr. Bowden’s “opinions [about the COVID-19 vaccine and treatments], which are harmful to the community, do not reflect reliable medical evidence.”

“For them to imply that what I’m doing is dangerous is the epitome of misinformation”. Bowden said.

Bowden says her opinions were not and are not harmful to patients or others in the community and the situation has turned her life upside down.

“I’m self-conscious now. In Houston, I go to the grocery store, and I wonder if people know who I am, and I worry about the safety of my children,” she said.

KPRC 2′s Re’Chelle Turner reached out to Houston Methodist for a comment but has not heard back.
Dr. Bowden and her attorney are expected to hold a press conference on Monday.

SEE MORE:
Houston Methodist doctor who resigned following suspension over controversial COVID-19 tweets believes hospital is ‘targeting her’

Houston Methodist suspends privileges of doctor following controversial tweets about COVID-19 treatments

Houston physician files $25M defamation lawsuit against Houston Methodist Hospital (click2houston.com)
 
Last edited:

Heliobas Disciple

TB Fanatic
(fair use applies)

Biden ‘feeling better every day’ as he recovers from COVID
By CHRIS MEGERIAN
yesterday

WASHINGTON (AP) — President Joe Biden said Monday that he’s “feeling better every day” as he recovers from his coronavirus infection, and the White House planned a summit on Tuesday to discuss developing a new generation of vaccines that could more effectively guard against contagious variants.

After participating in a virtual meeting to talk about computer chip manufacturing, Biden said “everything’s on the button” with the medical tests he’s been receiving each evening.

He also said he’s been sleeping better, joking that his dog had to wake him up Monday, the fourth day of Biden’s COVID isolation.

“My wife’s not here, she usually takes him out,” Biden said. Shortly before 7 a.m., he said, he felt “the nuzzle of my dog’s nose against my chest.” First lady Jill Biden has been at the family home in Delaware while the president isolates in the White House residence.

Biden said his voice remained raspy and said he still had nasal congestion, but he’s on his way “to fully recovered, God willing.”

“I’m not keeping the same hours, but I’m meeting all my requirements that have come before me,” he said.
It was Biden’s first public appearance since Friday. Although his voice was deeper and raspier than normal, a deep and persistent cough was all but gone.

Biden also delivered prerecorded remarks to the National Organization of Black Law Enforcement Executives conference in Orlando, Florida. He discussed the Capitol riot on Jan. 6, 2021.

The president, who tested positive last Thursday, was likely infected by the BA.5 variant. A new note Monday from Biden’s physician, Dr. Kevin O’Connor, said his symptoms have “almost completely resolved” and his vital signs remain “absolutely normal.”

Biden has been taking the antiviral drug Paxlovid.

Tuesday — Biden’s fifth day of isolation on the second floor, or living area, of the White House — will be an important moment on his road to continued recovery.

Dr. Ashish Jha, coordinator of the White House response to COVID-19, said Biden will be able to come out of isolation if he tests negative for the virus Tuesday using a rapid antigen test, while continuing to wear a well-fitting mask for the next several days.

Asked what kind of schedule Biden would then keep, Jha replied, “Let’s see when he tests negative.”

Separately, the vaccine summit on Tuesday, which involves top administration officials, scientists and pharmaceutical executives, comes as the country faces a surge of infections from BA.5, a variant that’s an offshoot of the omicron strain.

Although the current generation of vaccines, plus antiviral drugs, have helped prevent hospitalizations and deaths, there are hopes that new versions could provide more durable protection against disruptive infections.
 

Heliobas Disciple

TB Fanatic
(fair use applies)

President Biden's COVID-19 symptoms 'almost completely resolved,' physician says
Joey Garrison, USA TODAY
Mon, July 25, 2022, 4:16 PM

WASHINGTON — President Joe Biden's symptoms have "almost completely resolved" after testing positive for COVID-19 last week, his physician said Monday.

At this point, Biden is only reporting some residual nasal congestion and minimal hoarseness, Kevin O'Connor, physician to the president, said in a letter.

The president's symptoms have steadily improved each day since he tested positive for COVID-19 on Thursday. Biden's pulse, blood pressure, respiratory rate and temperature remain "absolutely normal," O'Connor said.

"The president continues to tolerate treatment well," he said. "He will continue Paxlovid as planned. He is experiencing no shortness of breath at all."

Biden, who remains in isolation at the White House, completed his fourth full day of Paxlovid, an antiviral treatment for the contagious disease, on Sunday. O'Connor said Biden will also continue taking a low-dose aspirin as an alternative type of blood thinner.

"I'm feeling great," Biden told reporters after holding a virtual event as the White House worked to show a president still on the job despite his illness. "I've had two full nights of sleep all the way through. As a matter of fact, my dog had to wake me up this morning. My wife's not here."

He added: "I think I'm on my way to a full and total recovery – God willing."

Biden's voice sounded raspy as he spoke with business executives and labor leaders by video to push for the Senate approval of the $52 billion Chips Act to boost the semiconductor industry. The president also addressed the National Organization of Black Law Enforcement Executives in a pre-recorded video released by the White House.

Took some calls this morning with man’s best co-worker. pic.twitter.com/dmkE5WhuvX
— President Biden (@POTUS) July 25, 2022

Earlier Monday, the White House publicized a photo of Biden on the telephone sitting next to Commander, his German Shepherd dog, on a White House patio. "Took calls this morning with man's best co-worker," Biden said in tweet.

Biden is believed to have been infected by the BA.5 omicron subvariant of COVID-19, which has proven highly transmissible. The strain is currently the most dominant in the U.S.

Biden remained at the White House over the weekend, canceling previous plans to visit Wilmington, Del, where first lady Jill Biden stayed. The president held no public events.

Biden is expected to complete five full days of isolation before being tested again for COVID-19 on Wednesday.
 

Heliobas Disciple

TB Fanatic
(fair use applies)
BOLDING MINE

Micronesia's first COVID-19 outbreak balloons, causing alarm
NICK PERRY
Tue, July 26, 2022, 1:40 AM

WELLINGTON, New Zealand (AP) — Micronesia's first outbreak of COVID-19 grew in one week to more than 1,000 cases by Tuesday, causing alarm in the Pacific island nation.

Last week, Micronesia likely became the final nation in the world with a population of more than 100,000 to experience an outbreak of the disease, after avoiding it for 2 1/2 years thanks to its geographic isolation and border controls.

Health officials said cases were rapidly increasing. It reported 140 new cases Monday, bringing the total to 1,261, a figure which includes some cases caught at the border before the outbreak.

Eight people have been hospitalized and one older man has died, officials said.

Many top lawmakers and senior officials have caught the disease, including Vice President Yosiwo George, who has been hospitalized, officials said. They said the vice president's condition was improving.

Camille Movick, whose family owns Fusion Restaurant in Pohnpei State, told The Associated Press that a lot of people have been posting on Facebook asking, for instance, that others stay away from their homes.

“Initially there was quite a bit of panic and worry with most people,” she said.

She said her restaurant remained open although business was slow because many people were afraid to dine in. She said some other restaurants had closed their dining rooms and were only offering takeaway services.

Movick said authorities had issued a directive that all people must wear masks in public — even outdoors — and that they faced fines of $1,000 for noncompliance.

She said one positive outcome was the outbreak had prompted many previously unvaccinated people to get their shots.

She said many people suspected the virus might have been circulating before the first community case was confirmed last week because health authorities weren't routinely testing patients for the disease.

Last year, Micronesia became one of the few countries to impose a broad mandate requiring all eligible citizens get vaccinated against the coronavirus.

The government threatened to withhold federal funds from any individuals or business owners who didn’t follow the rules. Health officials said this week that 75% of people aged 5 and over were fully vaccinated.

Movick said many parts of society were continuing to function as before, including many people who were working from their offices.

"We're hoping things get back to normal soon,” Movick said. “Just like in other countries, over time, they’ve gotten over it, and lifted the restrictions.”
 

Heliobas Disciple

TB Fanatic
(fair use applies)
Bolding mine (Geert related)

Australia's COVID hospital admissions, deaths rise as variant surges
by Renju Jose
Tue, July 26, 2022, 12:54 AM

SYDNEY (Reuters) - Hospital admissions for COVID-19 in Australia have reached a new high for a second straight day, data showed on Tuesday, while the daily death toll rose to its second-highest as an outbreak fuelled by a coronavirus sub-variant sweeps the country.

Nearly 5,600 patients infected with COVID are in hospital while 100 new deaths were reported, just short of a record 102 deaths on Saturday.

Nearly 330,000 infections have been reported over the last seven days but authorities say the real numbers could be double that.

"It's time to come together again and fight: get vaccinated, use a mask in crowds and indoors, and stay home if you're sick," said the premier of hard-hit Queensland state, Annastacia Palaszczuk.

The COVID flare-up is being driven by the highly infectious BA.4/5 Omicron sub-variant, and it is putting severe pressure on hospitals and retirement homes.

Queensland, battling its worst outbreak in the pandemic, expects its patient numbers to peak in around late August, modelling from the state's health department showed.

Along with rising hospitalisations, many front-line workers are off sick or in isolation, worsening the crisis.
Hospitals will add beds and shift more staff to front-line duties, Palaszczuk said.

In Victoria state, more than 8% of staff in the health sector, or about 10,000 employees, are off sick, Premier Daniel Andrews told reporters.

Like many countries, Australia has ditched its toughest coronavirus precautions and has been living with the virus since early this year.

Authorities are resisting the pressure to reinstate them, including calls from some doctors to make masks mandatory indoors.

Instead, they have urged businesses to let staff work from home and recommended people to get booster shots urgently.
About 71% of the eligible population have had boosters compared with 95% who had two shots.

In all, the country of nearly 26 million people has reported about 9.2 million COVID cases and 11,300 deaths.
 

Heliobas Disciple

TB Fanatic
(fair use applies)

White House to launch effort to develop next generation of Covid vaccines
By Matthew Herper and Lev Facher
July 25, 2022

The Biden administration is preparing a sweeping initiative to develop a next generation of Covid-19 immunizations that would thwart future coronavirus variants and dramatically reduce rates of coronavirus infection or transmission, building on current shots whose impact has been mainly to prevent serious illness and death, the White House told STAT.

To kick off the effort, the White House is gathering key federal officials, top scientists, and pharmaceutical executives including representatives of Pfizer and Moderna for a Tuesday “summit” to discuss the new technologies and lay out a road map for developing them.

“These are vaccines that are going to be far more durable, that are going to provide far longer-lasting protection, no matter what the virus does or how it evolves,” Ashish Jha, the White House Covid-19 response coordinator, said in an interview. “If we can drive down infections by 90% … Covid really begins to fade into the background, and becomes just one more respiratory illness that we have to deal with.”

Jha acknowledged that such a campaign would likely require more money from Congress, though he declined to provide a specific estimate.

The summit is the strongest sign of support to date for developing a new generation of Covid-19 vaccines — an effort that several prominent researchers have long advocated, but that has languished due to lack of investment. Several of those scientists praised the new White House initiative, expressing hope that it is a harbinger of bigger steps that will yield a next generation of Covid vaccines.

“I’m very thrilled they’re having this summit,” said Akiko Iwasaki, a researcher at Yale who conducted a promising study of a nasal vaccine booster and who co-founded a company that would seek to commercialize the technology. She will be attending the summit.

“It’s really important that the entire country be thinking about next-generation vaccines that may potentially prevent infection and transmission,” she said. “And that’s probably the only way to contain the spread of the virus.”

For all the initiative’s ambition, it is not without risk, both scientific and political. The Biden administration has struggled in recent months to execute a two-pronged messaging strategy: convincing Americans that the federal Covid response has been a success, while also stressing that the pandemic remains a clear and present danger. The vaccine initiative is likely to draw limited interest from the large segment of the public that would sooner act as if the virus threat is over. And it also risks wasting political capital on an initiative that would cost untold billions of dollars — and that lawmakers may be unwilling to fund.

Nonetheless, the administration is setting lofty goals.

One of the biggest hopes is for a new vaccine that would prevent infection no matter how the SARS-CoV-2 virus mutates. While current vaccines, like Pfizer’s and Moderna’s mRNA shots, are highly effective at preventing serious illness and death, they are less capable of preventing Covid from spreading. The recent emergence of new strains, like Omicron and its sublineages BA.4 and BA.5, have led the companies to develop new jabs specifically targeted at those variants, which should be available in the fall.

Experts, however, say that strategy is unsustainable.

“Variant chasing will never get us to where we need to be,” said Eric Topol, director and founder of the Scripps Research Translational Institute. “Variant chasing is a losing strategy. It’s temporally flawed and unacceptable.”

Jha said that there are two major strategies for creating a new vaccine, both of which likely require support from the federal government to develop, test, and manufacture.

One strategy would focus on the development of nasal vaccines that could create antibodies at the mucosal surfaces in the nose and elsewhere where viruses enter the body, thereby preventing infection and transmission. A second strategy would aim to create vaccine antigens that would work against a broader array of coronavirus strains, thereby providing more durable immunity. It may or may not be possible to combine the two strategies.

The scientific challenges ahead for either approach are massive, and will be even bigger if researchers hope to create a vaccine that both prevents infection and is resistant to variants.

A few studies have shown promise for the nasal approach, but among other issues, it’s not clear how long immunity from a nasal vaccine would last. More broadly, while researchers have found antibodies that appear to be effective against a wider variety of coronaviruses, there will be no guarantee that a new vaccine is “variant-proof” until it has been in use for several years.

Jha said that the administration’s current thinking was that the new technologies might be three to five years from broad use, but that the right investment could dramatically speed that timeline.

Scientific challenges aside, there’s also that matter of money — specifically, getting it from Congress, which has been increasingly resistant to allocating new funds for Covid efforts.

A government-backed initiative to develop a new generation of coronavirus vaccines would likely cost billions. The Trump administration spent $12.4 billion on Operation Warp Speed, its initial push to develop Covid-19 immunizations, in 2020 alone. The federal government continues to spend massive sums on vaccines: Last month, the Biden administration announced a new $3.2 billion contract with Pfizer to supply another 105 million doses.

In recent months, the administration has struggled to convince lawmakers that more funding is necessary for the ongoing Covid-19 response. Just last month, the White House repurposed $10 billion in existing funding to pay for vaccines and therapeutics, after a failed effort to convince Congress that it couldn’t make the purchases without new money.

Sen. Mitt Romney (R-Utah), in response, called the White House’s messaging “patently false.” Lawmakers still haven’t struck a deal to provide more cash for the Biden administration’s pandemic response.

Biden has also struggled to convince Americans that they should receive third or fourth vaccine doses, despite evidence that shows protection from shots wanes after several months. According to data from Centers for Disease Control and Prevention, as of late June, 71% of Americans over 5 have received the original two-dose vaccine series. But only 49% of those eligible received their first booster dose, and only 26% of those eligible for a second booster dose have received it.

Survey data from the Kaiser Family Foundation indicates that half of unvaccinated Americans say that nothing could convince them to receive a Covid vaccine. Only 3% of unvaccinated people surveyed told the KFF they would get vaccinated if a new vaccine prevented infection.

Still, Jha cast the next generation of vaccines as potentially transformative — not just in terms of their effectiveness, but in terms of the public’s interest.

“When we have a whole new platform of vaccines, I expect a vast majority of Americans to take it,” Jha said.

The regulatory requirements to determine the safety and efficacy of such next-generation vaccines are still unclear. Those decisions will eventually be made by the Food and Drug Administration. One challenge is that they will have to be better options than current vaccines, whose safety has been determined not only by huge clinical trials, but also by administration to billions of people.

“We have fantastic vaccines that are actually doing a lot of good right now and are quite safe,” Jha said. “And so the bar for approving new vaccines is going to be that it has to be better than that. And that’s going to be a high bar.”

While hospitalization rates remain low compared to the devastating Covid waves of January 2021, September 2021, and January 2022, they have steadily climbed since April, as contagious viral variants including BA.4 and BA.5 have rapidly spread. There is really no predicting, experts say, what the virus will throw at society next.

“There’s a sense that we’re playing catch-up with the virus,” Jha said. “The virus is constantly evolving. We’re having to evolve with it, that’s fine. But over the long run, we really need a serious breakthrough.”
 

Heliobas Disciple

TB Fanatic
I will be posting more on this study later on down the page.

Bolding mine


(fair use applies)

New studies offer theory on cause of unusual hepatitis cases in kids
By Helen Branswell
July 25, 2022

There is a new theory about what may be causing puzzling cases of pediatric hepatitis of unknown origin — and it is complex.

Two new and as-yet-unpublished studies from scientists in the United Kingdom theorize that children who have developed the hepatitis cases may have been co-infected with two different viruses and had a genetic predisposition to have an over-exuberant immune response when that happened.

Previously the leading hypothesis was that adenovirus 41, which had been found in a number of the infected children, was causing the liver damage. Adenovirus 41 has been known to trigger liver damage in immunocompromised children, but had never been seen to do so in children with intact immune systems.

But the new studies report finding the presence of something called adeno-associated virus 2 — AAV2 for short — in the blood and in liver tissues from a number of affected children. They also found the children were infected with adenoviruses or herpes viruses.

Adeno-associated virus 2 is what is known as a dependoparvovirus. It cannot replicate in a host’s cells unless another virus is present.

If correct, this theory does not rule out the possibility that adenovirus 41 may have played a role in the cases, said Angela Rasmussen, a virologist at the University of Saskatchewan’s Vaccine and Infectious Disease Organization.

“It suggests that AdV 41 (or another helper virus) is necessary but not sufficient,” she told STAT by email.

“If this is correct,” she added, “you need the combination of all three” — a helper virus, such as adenovirus 41, the adeno-associated virus 2, and the genetic predisposition.

In fact, Judy Breuer, senior author of one of the papers, said the group very much thinks that adenovirus — primarily but not exclusively adenovirus 41 — is involved. “We feel very certain that the adenovirus is playing a role in some way,” Breuer, a clinical virologist at University College London and a consultant at Great Ormond Street Hospital for Children, told STAT in an interview.

Adeno-associated viruses are not typically looked for when clinicians are trying to figure out the cause of an illness, she said, because they haven’t been thought to be harmful. But her group cast a very wide net when studying samples from some of the children in the outbreak, not looking to see if a particular pathogen was present but to get a picture of all the possible disease agents their specimens contained.

She warned, though, that it is still possible that AAV2 is a bystander, not part of the cause of these hepatitis cases.

Meanwhile the second group of scientists, who are mostly from Scotland, looked at the genetic makeup of a group of affected children there. Eight of nine children studied had a particular genetic variant that affects the way the immune system responds to a threat. Nearly 16% of blood donors from Scotland have this genetic mutation. Doctors in Scotland were among the first to report on the unusual hepatitis cases in the spring.

“The fact that these children had this particular immune genetic makeup … we hypothesize that it made them susceptible to a new overreaction to one or both of the viruses,” Breuer said.

Mario Koopmans, head of the department of viroscience at Erasmus Medical Center in Rotterdam, the Netherlands, said the theory is worthy of further investigation, but at this point is not conclusive. It “does suggest there is something to the combination of AAV2 and Adeno or possibly other viruses,” she said in an email.

The new studies still must go through peer review. But if they are correct, they will help to explain why some medical centers that treat children with liver ailments have seen what appear to be unusual numbers of cases of unexplained hepatitis starting last fall and through the spring.

More than 1,000 such cases from 35 countries have been reported to the World Health Organization. Of that total, 22 children have died and 46 have needed liver transplants. In the United States, 355 possible cases are under investigation, the Centers for Disease Control and Prevention says. As of late June, 20 of those children had required liver transplants and 11 had died.

The studies also suggested that the disruption of normal life triggered by the pandemic may have contributed to increased transmission of adeno-associated virus 2 and adenoviruses when Covid-19 control measures started to ease, because more children would have been susceptible to them. That, in turn, would have led to an increased number of cases of hepatitis in children.

“The current outbreak followed relaxation of restrictions due to the pandemic and represented one of many infections, including other enteric pathogens such as norovirus, that occurred in UK children following return to normal [social] mixing,” Breuer and her co-authors wrote.

Koopmans agreed. “The combination of two viruses and a genetic susceptibility factor does fit the hypothesis that the elevation in cases became visible due to the unusual occurrence of ‘common’ infections, as the patterns for several endemic viruses were disturbed by the COVID 19 control measures.”

Alasdair Munro, a clinical research fellow in pediatric infectious diseases at Britain’s University Hospital Southampton, found the papers persuasive.

“Everything seems to fit, will be interesting to see if further examination can confirm this as the cause — hopefully putting to bed some of the debates,” he wrote on Twitter.

But Rasmussen cautioned that there are more pieces of the puzzle to be found, including how this trio of factors would cause the damage that has been seen.

“I think the important things to keep in mind here are that this is correlation, not causation,” she wrote. “More work will be required to establish this as the cause, including figuring out the mechanism.”

She also suggested it would be good if other groups could replicate the findings seen in these two groups of children from the U.K. “I would hope that all other investigators who have reported on these cases outside the U.K. are checking their sequence data for AAV2 sequences as well as doing some … genotyping.”

The unexplained cases of pediatric hepatitis have ignited heated and even ugly debate on Twitter, with a number of scientists and physicians insisting that those investigating the seeming outbreak were ignoring what appeared to be obvious — that the illness was likely a consequence of previous Covid infection.

The efforts to figure out what was behind the cases — and whether indeed there was an outbreak underway — were complicated by the fact that data from the United States showed there had not been an increase in pediatric hepatitis of unknown origin, or liver transplants for pediatric hepatitis, or even of adenovirus 41 infections in the past year compared to prior to the pandemic. That does not mean there might not have been an increase in cases caused by this constellation of triggers, just that the overall number of cases of pediatric hepatitis for which a cause was not found had not changed.
 

Heliobas Disciple

TB Fanatic
Keep in mind that Paxlovid, which is used widely now in the USA (Fauci and Biden both took it), is made up of two drugs, one of which started out as an HIV drug.


(fair use applies)

China Approves HIV Drug For COVID Patients
by Tyler Durden
Monday, Jul 25, 2022 - 05:45 PM

China on Monday gave a conditional green light to repurpose a drug, which is typically used to threat certain HIV-1 virus infections, for "normal type" COVID infections, Reuters reports, citing the National Medical Products Administration.

The drug, Azvudine, is made by Genuine Biotech, was approved in July 2021 to treat specific HIV infections.

In a late-stage clinical trial, 40.4% of patients taking Azvudine showed improvement in symptoms seven days after first taking the drug, compared with 10.9% in the control group, Henan province-based Genuine Biotech said in a statement earlier this month, without providing detailed readings. -Reuters

"Normal type" COVID is defined as coronavirus infections which include signs of pneumonia, but where the patient hasn't progressed to a severe stage.

The drug's approval marks the latest step in China's shift from a "zero Covid" policy of lockdowns, to accepting that the virus is now endemic - and apparently can be treated with an AIDS medication.

The availability of effective COVID vaccines and treatments is crucial in laying the groundwork for China's potential pivoting from its "dynamic COVID zero" policy, which aims to eliminate every outbreak - however small - and relies on mass testing and strict quarantining. -Reuters

In February, China approved Pfizer's oral Paxlovid treatment for adults suffering mild-to-moderate COVID who are at high risk of progressing to severe disease.
 

Heliobas Disciple

TB Fanatic
(fair use applies)

Erectile dysfunction and incontinence could be symptoms of long Covid, according to new research
  • Researchers from the University of Birmingham analysed 2.4 million people
  • Included 486,149 people with prior infection and 1.9 million with no indication
  • Most common symptoms included loss of smell and shortness of breath
By Jonathan Rose For Mailonline
Published: 20:53 EDT, 25 July 2022 | Updated: 21:19 EDT, 25 July 2022

Erectile dysfunction and incontinence could be symptoms of long Covid, according to new research.

Researchers from the University of Birmingham analysed anonymised electronic health records of 2.4 million people in the UK.

The data, taken between January 2020 and April 2021, comprised of 486,149 people with prior infection and 1.9 million people with no indication of it.

The research was funded by the National Institute for Health and Care Research and UK Research and Innovation.

The scientists found the most common symptoms included loss of sense of smell, shortness of breath, chest pain and fever, The Times reports.

Others included amnesia, apraxia (the inability to perform familiar movements or commands), bowel incontinence, erectile dysfunction, hallucinations and limb swelling.

The study, published Monday in Nature Medicine, found that patients reported 62 symptoms much more frequently 12 weeks after initial infection.

Dr Shamil Haroon, the senior author on the study, said: 'This research validates what patients have been telling clinicians and policy makers throughout the pandemic, that the symptoms of long COVID are extremely broad and cannot be fully accounted for by other factors such as lifestyle risk factors or chronic health conditions.

'The symptoms we identified should help clinicians and clinical guideline developers to improve the assessment of patients with long-term effects from COVID-19, and to subsequently consider how this symptom burden can be best managed.'

Co-author Jennifer Camaradou said: 'This study is instrumental in creating and adding further value to understanding the complexity and pathology of long COVID.

'It highlights the degree and diversity of expression of symptoms between different clusters.
'Patients with pre-existing health conditions will also welcome the additional analysis on risk factors.'
 

Heliobas Disciple

TB Fanatic
(fair use applies)

Australian Researchers Develop Semi-Permanent Virus and Bacteria Repellent Surface Spray
By Steve Milne
July 25, 2022

A team of researchers from several Australian universities have developed a first-of-its-kind spray that can prevent the spread of bacterial and viral infections—including COVID-19—on a multitude of surfaces for prolonged periods.

The spray coating, which uses a combination of plastics strong enough to compare with bullet-proof glass, can repel viruses and bacteria via an air-filled barrier but also kill them through microscopic materials if the coating layer becomes damaged or submerged for a long time.

With disinfectants becoming less effective and requiring regular reapplication, the new coating—applied like spray paint—can step in to provide a long-lasting surface layer proven to protect surfaces from these pathogens.

The spray was found to be 99.85 percent resistant to gram positive and gram negative bacteria, which despite being structurally different, can both develop resistance to antibiotics.

The researchers also state that the spray is safer than existing alternatives to disinfectant, such as silver nanoparticles, with no known side effects.

Co-lead author of the paper on the spray, Melbourne University’s Professor David Nisbet, said in a release on Thursday that the coating could be applied to surfaces in hospitals, nursing homes, schools, and restaurants, as well as to lift buttons and stair rails to prevent the spread of common viruses and bacteria.

“We have tested this spray on bricks, plastic, cloth, blotting paper, leather, metal, glass etc. Effectively we can coat most surfaces,” Nisbet told The Epoch Times.

He added that the coating is chemically inactive and protected by a layer of air in a liquid medium, so it’s unlikely that another substance could react with the coating and render it less effective.

Durability and Water Repellent Qualities

Nisbet said the coating has been engineered using a simple and scalable technique, with a careful choice of materials to ensure “ultra-durability”, and the need for reapplication would depend on the amount of use the surface gets.

“In principle, in areas of normal abrasion use, I would predict it would only need to be reapplied every 12-24 months,” he said.

Meanwhile, the co-lead author from the University of Sydney’s School of Biomedical Engineering, Prof. Antonio Tricoli, said that without barriers, coronaviruses could stay on surfaces and remain infectious for up to a week, while reoviruses, responsible for colds or diarrhoea, can remain on surfaces for several weeks.

“Like a lotus leaf, the surface spray creates a coating that repels water. Because the pathogens like to be in the water, they remain trapped in the droplets, and the surface is protected from contamination,” he said.

If this mechanism fails, a secondary burst release of ions is triggered by carefully designed nanomaterials dispersed in the coating.”

The spray was developed through a five-year collaboration by a multi-university team, whose researchers have established a start-up company and hope to make the spray commercially available within three years.
 

Heliobas Disciple

TB Fanatic
(fair use applies)

COVID-19 Vaccination Rates Among Children Under 5 Have Already Peaked: Analysis
By Zachary Stieber
July 25, 2022

The COVID-19 vaccination rates for small children have already peaked just weeks after two of the vaccines were authorized for the age group, according to a new analysis.

U.S. officials in mid-June authorized and recommended the Pfizer and Moderna vaccines for virtually all children aged 6 months to 5 years.

Uptake of the vaccines among young children climbed in the initial days following the moves, but peaked on July 1 and has since dropped, according to an analysis of Centers for Disease Control and Prevention (CDC) data by the Kaiser Family Foundation.

Just 2.8 percent of the approximately 19 million children in the age group have received at least one dose of a COVID-19 vaccine as of July 20, a small increase from 1.3 percent in early July.

That’s well below the percentages among other pediatric age groups.

One month after 5- to 11-year-olds could get Pfizer’s vaccine, for instance, 16.7 percent had received at least one dose.

On the other hand, uptake has slowed with each successive age group.

Seven out of 10 children aged 12 to 17, who were cleared to receive the vaccine in late 2020 or early 2021, have received at least one dose to date. But just 37 percent of the 5 to 11 group have gotten one or more doses, according to CDC data.

“This slow uptake likely reflects a range of factors. In addition to there being fewer access points for those under the age of 5, our prior COVID-19 Vaccine Monitor Surveys, fielded before children under 5 became eligible for vaccination, found that most parents were cautious about getting their young children vaccinated; soon-to-be-released survey data will show that this caution has continued even after the CDC recommended vaccination for those 6 months and older,” Kaiser Family Foundation analysts Jennifer Kates and Stephanie Oum wrote.

“As a result, many parents may not encounter an offer of a vaccine until they go in for a routine visit to a pediatrician at some point in the year.”

Most Have Had COVID-19

Some experts have previously noted that the clinical trials for the vaccines for small children showed substandard or unreliable efficacy results against infection, and were unable to provide estimates for efficacy against severe disease.

Further, children are far less likely than adults to experience severe illness if they do contract SARS-CoV-2, the virus that causes COVID-19, studies have shown. And about 71 percent of the youngest children have recovered from COVID-19, giving them a measure of protection against infection and strong shielding from severe cases.

U.S. government officials have continued urging parents to take their children to get one of the vaccines, asserting they will be safer after having received one.

But the low vaccination rates since emergency authorization show the “wisdom of the crowd,” Dr. Vinay Prasad, a professor in the Department of Epidemiology and Biostatistics at the University of California San Francisco, wrote on Twitter. “I have yet to see any good data showing these [vaccines] help a healthy kid who had covid,” he said.
 

Heliobas Disciple

TB Fanatic
(fair use applies)

Fauci: We Were ‘Always Aware’ of Natural Immunity
By Jack Phillips
July 25, 2022

White House adviser Anthony Fauci said Monday that he and other health officials were “always aware” of the protection afforded by COVID-19 natural immunity.

“We were always aware that if you get infected, you have a degree of protection against reinfection,” Fauci remarked in response to a question from a reporter with The Hill.

He later said that the protection afforded by natural immunity and vaccination “wanes over a period of time,” which is “very, very different” from other infections like polio, smallpox, and measles.

“The people who were talking about natural immunity were making an assumption … that once you get infected, you are essentially protected very, very well for a period of time,” Fauci said. He claimed that individuals who have been infected and vaccinated have the best protection, describing that phenomenon as “hybrid immunity.”

Throughout the course of the COVID-19 pandemic, Fauci and other federal health officials have favored COVID-19 vaccinations over natural immunity and have frequently urged Americans to get both vaccines and booster shots, while often suggesting that unvaccinated individuals were to blame for the continued spread of the virus.

On July 11, 2021, Fauci also called on local governments and schools to require COVID-19 vaccines, telling CNN that “there should be more mandates.”

The Biden administration last September also tried to issue a sweeping vaccine mandate for tens of millions of workers at private businesses, which was ultimately struck down by the Supreme Court in January as well as a mandate requiring most health care staff to receive the shots. When asked about the vaccine mandates in October 2021, Fauci defended the administration’s policies.

“Things like mandating, be they masks or vaccinations, they’re very important,” Fauci told Fox News on Oct. 17, 2021. “We’re not living in a vacuum as individuals. We’re living in a society, and society needs to be protected. And you do that by not only protecting yourself but by protecting the people around you, by getting vaccinated.”

However, Fauci conceded on July 13 that COVID-19 vaccines aren’t effective at preventing the transmission of the virus. Instead, the shots are better at protecting individuals from severe symptoms and hospitalizations, he added.

“One of the things that’s clear from the data [is] that … vaccines—because of the high degree of transmissibility of this virus—don’t protect overly well, as it were, against infection,” he told Fox News.

Although Fauci has headed the National Institute of Allergy and Infectious Disease for nearly 30 years, he became a household name in early 2020 when he began delivering interviews to media outlets about the COVID-19 pandemic, essentially serving as the federal government’s top pandemic spokesperson.

In clarifying remarks last week, Fauci said that he is “not going to retire” and “may step down from my current position at some time.”
 

Heliobas Disciple

TB Fanatic
This is the video that the article above this is talking about. I started to watch it and then started to take notes because it was that good a video. Yes it's Fauci but they ask him tough questions, especially the woman. I was cheering her on, and Fauci got touchy back at her so if you have time, watch.

View: https://www.youtube.com/watch?v=WXrWTkEjDtQ
Dr. Anthony Fauci EXCLUSIVE: MORE Stringent Response Had Fauci Known Then What He Knows Now
20 min 10 sec

Jul 25, 2022
The Hill

Dr. Anthony Fauci, the director of the National Institute of Allergy and Infectious Diseases, weighs in on COVID related decisions made since the start of the pandemic.

My notes, started a few minutes in when I realized this was a great video: He says that masks would have done differently had he known then what he knows now. That KN95 would've been important, and they are very good of acquisition of and transmission of infection. Right now he is clear that masks do work but has to be high quality and well fit. N95 or KN95. Question: Why was mass antibody testing never part of covid response and why was natural immunity ever taken seriously and do you regret that? Says always aware if you get infected you have a degree of protection against reinfection. Clear now (not then) that the protection of natural infection and from vaccines wanes over time. Tells questioner her question wasn't fair! (unbelievable). You have to be open minded to deal what dealing with in real world is elusive target. Other journalist says I thought we're open to question and debate. Do you hear that criticism? Brings up monkeypox and that they're not ready for it. Same errors that were made in early days of covid. Says he always had/has an open mind and takes from the community. (unbelievable again). Takes criticism seriously (right after he told off the woman questioner). Woman again -questions school closing was a disaster (you have to watch just to watch this woman, she's great, and getting under his skin which you can tell by how he answers her). Would he recommend locking down schools again. He denies he said they should lock down schools. (someone needs to fact check that). Closing schools should be a last resort (also needs to be fact checked if he said that). Asking about lab leak and gain of function research - what are benefits of that type of research. We didn't get vaccines from that so it didn't help, why do it? He says they are using gain of function wrong. You have to examine in the field and need understanding and protecting. we put guardrails up. outside committees. they came up with them for bat viruses and viruses from the environment with sars cov2 and mers. Followed those guardrails. misconception about GoF as a category as opposed to a certain situation whether the benefit outweighs risk and the risks are under guardrails. He makes one point --research funded by NIH, the viruses studied there (people interrupt and he never gets to say this) - the viruses studied and published, any card carrying virologist who knows about viral evolution would tell you it's impossible for those viruses to turn into SarsCov2 by accident or on purpose. Impossible. But research funded by NIH, people make an inappropriate conflation with those experiments and sarcov2. Does he keep an open minded about funding chinese scientists - could a lab leak be a possibility? of course, he keeps an open eye. See what was studied and published though and still say if you keep an open mind the most likely evolution is a natural jumping of species. Have to go with the data.
 

Heliobas Disciple

TB Fanatic
After reading the comments on that video I learned that that program has an even tougher covid reporter so I looked to find one of her videos, it's from a few days ago. She's great too, this is a channel I will try to check in with more often now that I discovered them.

View: https://www.youtube.com/watch?v=V0o_7fusKxM
Kim Iversen: Does mRNA Change Your DNA? Breaking Down AP and Reuters Fact Check
12 min 20 sec

Premiered Jul 21, 2022


Kim Iversen breaks down the Associate Press and Reuters' fact check on the true impact of mRNA vaccines.

According to the CDC mRNA vaccines do not contain any live virus. Instead, they work by teaching our cells to make a harmless piece of a “spike protein,” which is found on the surface of the virus that causes COVID-19. After making the protein piece, cells display it on their surface. Our immune system then recognizes that it does not belong there and responds to get rid of it. When an immune response begins, antibodies are produced, creating the same response that happens in a natural infection.

In contrast to mRNA vaccines, many other vaccines use a piece of, or weakened version of, the germ that the vaccine protects against. This is how the measles and flu vaccines work. When a weakened or small part of the virus is introduced to your body, you make antibodies to help protect against future infection.

Both messenger RNA (mRNA) and viral vector COVID-19 vaccines work by delivering instructions (genetic material) to our cells to start building protection against the virus that causes COVID-19.

After the body produces an immune response, it discards all the vaccine ingredients just as it would discard any information that cells no longer need. This process is a part of normal body functioning.

The genetic material delivered by mRNA vaccines never enters the nucleus of your cells, which is where your DNA is kept. Viral vector COVID-19 vaccines deliver genetic material to the cell nucleus to allow our cells to build protection against COVID-19. However, the vector virus does not have the machinery needed to integrate its genetic material into our DNA, so it cannot alter our DNA.

According to the CDC all COVID-19 vaccines currently available in the United States are effective at preventing COVID-19. Getting sick with COVID-19 can offer some protection from future illness, sometimes called “natural immunity,” but the level of protection people get from having COVID-19 may vary depending on how mild or severe their illness was, the time since their infection, and their age.

Getting a COVID-19 vaccination is also a safer way to build protection than getting sick with COVID-19. COVID-19 vaccination helps protect you by creating an antibody response without you having to experience sickness. Getting vaccinated yourself may also protect people around you, particularly people at increased risk for severe illness from COVID-19. Getting sick with COVID-19 can cause severe illness or death, and we can’t reliably predict who will have mild or severe illness. If you get sick, you can spread COVID-19 to others. You can also continue to have long-term health issues after COVID-19 infection.

While COVID-19 vaccines are effective, studies have shown some declines in vaccine effectiveness against infections over time, especially when the Delta variant was circulating widely. "
 

Heliobas Disciple

TB Fanatic
View: https://www.youtube.com/watch?v=QY13ZGpjO_w
Early Treatment with GABA Reduces SEVERE COVID and Deaths in Mice (Study)
45 min 53 sec

Streamed live 5 hours ago
Drbeen Medical Lectures

Early Treatment with GABA Reduces SEVERE COVID in Mice (Study)
In this study researchers demonstrate how early treatment with GABA protected mice infected with SARS-COV-2 from death. Let's review.
Note: preprint study.

URL list from Monday, Jul. 25 2022

GABA-receptors are a new druggable target for limiting disease severity, lung viral load, and death in SARS-CoV-2 infected mice | bioRxiv
...

GABA-receptors are a new druggable target for limiting disease severity, lung viral load, and death in SARS-CoV-2 infected mice
...
 

Heliobas Disciple

TB Fanatic
View: https://www.youtube.com/watch?v=098CixL_y6M
Do COVID-19 vaccines prevent death in children? - Singapore update
12 min 17 sec

Streamed live on Jul 24, 2022
Vejon Health

The most comprehensive review of childhood vaccination status occurred between January and April 2022.
Here is an update on the outcomes.
Tan, Sharon, et al. "Effectiveness of BNT162b2 Vaccine against Omicron in Children 5 to 11 Years." Available at SSRN 4052133 (2022).
...
 

Heliobas Disciple

TB Fanatic
(fair use applies)

When friendly forces become foes: Scientists blunt the impact of natural killer cells to improve vaccine effectiveness
by Delthia Ricks, Medical Xpress
July 25, 2022


1658822880429.jpeg
PD-1 dependent NK cell regulation of CD8+T-cells. C57BL/6 mice were infected with an adenoviral vector encoding the HBV genome and treated with anti-NK1.1 (⍺NK) or isotype control antibody prior to therapeutic vaccination. Intrahepatic lymphocytes were harvested 14 days after immunization. (A) Quantitative real-time PCR analysis of HBsAg mRNA extracted from the liver of infected mice. (B) Representative plot of CD8+T-cells isolated from the spleen of CD45.2 PD-1KO or CD45.1 wild-type (WT) mice transferred to opposite congenic mouse recipient one day prior to therapeutic vaccination. Example of PD-1 expression and IFNy production on transferred PD-1KO and WT CD8+ T-cells. *, p<0.05; p-values were determined by Kruskal-Wallis test (ANOVA) with a post hoc test for multiple comparisons (n=5 mice per group; two experiments combined). Credit: Science Translational Medicine (2022). DOI: 10.1126/scitranslmed.abi4670

Scientists have discovered that the body's own natural killer cells can suppress the immune benefits of therapeutic vaccines, a problem that can affect inoculations against chronic viral infections and cancer.

Indeed, the scientific literature is replete with examples of otherwise effective vaccines sometimes proving impotent. Increasingly, the reasons are pointing to an enemy within the body itself: a friend that transforms into a foe.

Scientists at University College London have been investigating the conundrum and have turned to an animal model to decipher how natural killer cells inadvertently blunt the benefits of vaccines.

In Science Translational Medicine, Dr. Mariana O. Diniz and colleagues report that natural killer cells can react so overwhelmingly after vaccination that they negatively impact a critical constituent of the immune response—CD8+T cells. This vital population can become overworked and exhausted, Diniz and her collaborators found, a phenomenon that causes vaccination to have little effectiveness.

"Therapeutic vaccines for chronic infections have reduced efficacy because of the presence of exhausted T cells and [an] environment that limits vaccine responses," wrote Diniz, noting that the problem invariably begins with the aggression of natural killer cells.

Working with a mouse model, Diniz and colleagues have found that a combination treatment can boost robust immune responses after vaccination by acting on natural killer cells. The strategy, the team said, may eventually prove useful in the design and improvement of therapeutic vaccines for chronic viral infections and cancers.

"A better understanding of the mechanisms that regulate CD8+T cell responses to therapeutic vaccines is needed to develop approaches to enhance vaccine efficacy for chronic viral infections and cancers," Diniz and the UCL team asserted in the journal.

Part of their research involved gaining an intimate knowledge of natural killer cells themselves, a population whose name alone can invoke potent images of destruction.

Natural killer cells are produced in the bone marrow as well as other sites throughout the body. Also known simply as a natural killer, or just a plain old NK cell, this population is a type of white blood cell containing granules—microscopic particles—with enzymes capable of killing tumor cells or cells infected with a virus.

Natural killers were initially thought to develop exclusively in the bone marrow, but relatively recent evidence in humans and mice suggests that these cells can also develop and mature in secondary lymphoid tissues, such as the tonsils, spleen and lymph nodes.

The killers are a type of immune cell and are crucial constituents of the innate immune system, the body's rapid response network. It is present at birth and the immune response that is first on the scene in the event of an infection or cancer. The innate system exists separately from the adaptive immune system, which emerges around 12 months of age. The adaptive system, also known as acquired immunity, is composed of an array of specialized immune cells—T cells, B cells and protein antibodies—that seek and destroy foreign invaders.

While the innate immune system is noted for its rapid response, the adaptive is known for its recall and the ability to pounce on threats faster in the future by relying on its memory of the same invaders from the past.

The aim of the UCL research was to turn natural killer cells from foe to friend in situations of vaccination for chronic conditions. The team's investigation revealed that natural killers impaired the response of T cells in mice to ChAdOx1-HBV, an experimental vaccine for chronic hepatitis B virus infection.

The scientists found that hepatitis B infection heightened the expression of the PD-L1 protein on the surface of natural killer cells in the liver, which in turn suppressed T cells that had been primed by the vaccine.

However, depleting the natural killer cells enhanced T cell responses in mice after vaccination. Alternatively, the researchers found they could convert natural killer cells into immune-boosting helpers by administering an anti-PD-L1 antibody before vaccination, leading to even stronger hepatitis B virus-specific T cell responses.

The team then applied a similar approach to cell samples from patients with chronic hepatitis B and discovered that the strategy can also yield benefits for humans.

"Our findings delineate an immunotherapeutic combination that can boost the response to therapeutic vaccination in chronic hepatitis B and highlight the broader importance of PD-L1–dependent regulation of T cells by cytokine-activated natural killer cells," Diniz concluded.
 

Heliobas Disciple

TB Fanatic
(fair use applies)

Researchers use wearable tech to detect COVID-19 before onset of symptoms
by Jesse Dorey, McMaster University
July 25, 2022

Wrist-worn health devices can be combined with machine learning to detect COVID-19 infections as early as two days before symptoms appear, McMaster researcher David Conen and a team of experts from across Europe have determined.

The COVI-GAPP study, born out of a larger research project based in Lichtenstein, was conducted by researchers from McMaster, the Dr. Risch Medical Laboratory, the University of Basel in Switzerland and Imperial College London.

Based on the team's findings, which were published last month in BMJ Open, another group of researchers have begun a larger study, which could open the door to applying the use of wearable health tech for the early detection of other infectious diseases.

The aim of the COVI-GAPP study was to determine if existing wearable health devices could be paired with machine learning technology to detect presymptomatic and asymptomatic COVID-19 infections.

"When the pandemic started in March 2020," Conen explains, "we quickly thought about how we could […] contribute to the knowledge gain and help to prevent and treat patients with COVID and help to avoid or better treat and better handle future pandemics."

COVID-19 symptoms typically take a few days to appear, during which time the infected person can unknowingly spread the virus to others.

"If you can isolate those patients with COVID or whatever future infection there is, then this could have great implications for public health," says Conen, an associate professor of medicine in the Faculty of Health Sciences and a scientist at the Population Health Research Institute. "This [study] is related to multiple different infections or other diseases where you can use those algorithms to identify people early and either try to prevent complications, isolate the patients when it's a very contagious disease, and change treatments."

The study collected data from 1,163 participants from March 2020 until April 2021. Participants wore an AVA fertility tracker, a commercially available, FDA- and European agency-approved health bracelet that monitors breathing rate, heart rate, heart rate variability, skin temperature and blood flow at night while sleeping.

The bracelet was synchronized to a modified mobile app that was used to record any activity that might affect the body's central nervous system, such as alcohol use and prescription or recreational drug intake, as well as any potential COVID-19 symptoms.

127 participants tested positive for COVID-19 during the study. The bracelet picked up noticeable changes in all five physiological indicators during all stages of infection.

Based on the information that was provided by the patients, an algorithm was trained to detect COVID-19 symptoms in 70% of the participants who tested positive for the virus. 73% of confirmed positive cases were detected up to two days prior to symptoms appearing in the training stage.

The algorithm was then tested against the remaining 30% of participants. Results were similar in the testing stage, as the algorithm was able to detect 68% of the positive cases as early as two days before the onset of symptoms.

"That an existing medical device is able to be used in a different meaning [shows] that wearables have a promising future," says Conen.

The original participatory study was conducted with a relatively small group of participants, and the group lacked diversity in ethnicity, age, and geographic location, the research team notes.

To address these challenges and further test the efficacy of wearable health devices and machine learning in COVID-19 detection, a much larger study of 20,000 participants is being conducted in the Netherlands. The researchers expect to publish its results later this year.

Conen looks forward to those results and the potential for this technology to have applications beyond COVID-19 detection.

"This is not related only to COVID," he says. "In future diseases, it could also lead to preventative treatments and prevent significant complications."
 

Heliobas Disciple

TB Fanatic
(fair use applies)

CRISPR therapeutics can damage the genome
by Tel Aviv University
July 25, 2022

Researchers at Tel Aviv University warn that CRISPR therapeutics can damage the genome. They caution: "The CRISPR genome editing method is very effective, but not always safe. Sometimes cleaved chromosomes do not recover and genomic stability is compromised—which in the long run might promote cancer."

A new study from TAU identifies risks in the use of CRISPR therapeutics—an innovative, Nobel-prize-winning method that involves cleaving and editing DNA, already employed for the treatment of conditions like cancer, liver and intestinal diseases, and genetic syndromes. Investigating the impact of this technology on T-cells—white blood cells of the immune system, the researchers detected a loss of genetic material in a significant percentage—up to 10% of the treated cells. They explain that such loss can lead to destabilization of the genome, which might cause cancer.

The study was led by Dr. Adi Barzel from the School of Neurobiology, Biochemistry and Biophysics at TAU's Wise Faculty of Life Sciences and Dotan Center for Advanced Therapies, a collaboration between the Tel Aviv Sourasky Medical Center (Ichilov) and Tel Aviv University, and by Dr. Asaf Madi and Dr. Uri Ben-David from TAU's Faculty of Medicine and Edmond J. Safra Center for Bioinformatics. The findings were published in the scientific journal Nature Biotechnology.

The researchers explain that CRISPR is a groundbreaking technology for editing DNA—cleaving DNA sequences at certain locations in order to delete unwanted segments, or alternately repair or insert beneficial segments. Developed about a decade ago, the technology has already proved impressively effective in treating a range of diseases—cancer, liver diseases, genetic syndromes, and more. The first approved clinical trial ever to use CRISPR, was conducted in 2020 at the University of Pennsylvania, when researchers applied the method to T-cells—white blood cells of the immune system. Taking T-cells from a donor, they expressed an engineered receptor targeting cancer cells, while using CRISPR to destroy genes coding for the original receptor—which otherwise might have caused the T-cells to attack cells in the recipient's body.

In the present study, the researchers sought to examine whether the potential benefits of CRISPR therapeutics might be offset by risks resulting from the cleavage itself, assuming that broken DNA is not always able to recover.

Dr. Ben-David and his research associate Eli Reuveni explain: "The genome in our cells often breaks due to natural causes, but usually it is able to repair itself, with no harm done. Still, sometimes a certain chromosome is unable to bounce back, and large sections, or even the entire chromosome, are lost. Such chromosomal disruptions can destabilize the genome, and we often see this in cancer cells. Thus, CRISPR therapeutics, in which DNA is cleaved intentionally as a means for treating cancer, might, in extreme scenarios, actually promote malignancies."

To examine the extent of potential damage, the researchers repeated the 2020 Pennsylvania experiment, cleaving the T-cells' genome in exactly the same locations—chromosomes 2, 7, and 14 (of the human genome's 23 pairs of chromosomes). Using a state-of-the-art technology called single-cell RNA sequencing they analyzed each cell separately and measured the expression levels of each chromosome in every cell.

In this way, a significant loss of genetic material was detected in some of the cells. For example, when Chromosome 14 had been cleaved, about 5% of the cells showed little or no expression of this chromosome. When all chromosomes were cleaved simultaneously, the damage increased, with 9%, 10%, and 3% of the cells unable to repair the break in chromosomes 14, 7 and 2 respectively. The three chromosomes did differ, however, in the extent of the damage they sustained.

Dr. Madi and his student Ella Goldschmidt explain: "Single-cell RNA sequencing and computational analyses enabled us to obtain very precise results. We found that the cause for the difference in damage was the exact place of the cleaving on each of the three chromosomes. Altogether, our findings indicate that over 9% of the T-cells genetically edited with the CRISPR technique had lost a significant amount of genetic material. Such loss can lead to destabilization of the genome, which might promote cancer."

Based on their findings, the researchers caution that extra care should be taken when using CRISPR therapeutics. They also propose alternative, less risky, methods, for specific medical procedures, and recommend further research into two kinds of potential solutions: reducing the production of damaged cells or identifying damaged cells and removing them before the material is administered to the patient.

Dr. Barzel and his Ph.D. student Alessio Nahmad conclude: "Our intention in this study was to shed light on potential risks in the use of CRISPR therapeutics. We did this even though we are aware of the technology's substantial advantages. In fact, in other studies we have developed CRISPR-based treatments, including a promising therapy for AIDS. We have even established two companies—one using CRISPR and the other deliberately avoiding this technology. In other words, we advance this highly effective technology, while at the same time cautioning against its potential dangers. This may seem like a contradiction, but as scientists we are quite proud of our approach, because we believe that this is the very essence of science: we don't 'choose sides." We examine all aspects of an issue, both positive and negative, and look for answers."
 

Heliobas Disciple

TB Fanatic
(fair use applies)

SARS-CoV-2 variants have developed resistance to human interferons
by Kelsea Pieters, University of Colorado School of Medicine
July 25, 2022

Researchers at the University of Colorado Anschutz Medical Campus have investigated how antiviral proteins called interferons interact with SARS-CoV-2, the cause of COVID-19. The study, published in Proceedings of the National Academy of Sciences, focuses on how the innate arm of the immune system defends against this coronavirus. The work resulted from a collaborative effort by multiple scientists, including the laboratories of Mario Santiago, Ph.D., associate professor of medicine and Eric Poeschla, MD, professor of medicine, both at the University of Colorado School of Medicine.

While the adaptive arm of the immune system responds definitively to infection by generating antibodies and T cells, the innate arm forms an earlier, first line of defense by recognizing conserved molecular patterns in pathogens. "SARS-CoV-2 just recently crossed the species barrier into humans and continues to adapt to its new host," says Poeschla. "Much attention has deservedly focused on the virus's serial evasions of neutralizing antibodies. The virus seems to be adapting to evade innate responses as well."

Interferons are central molecules in the innate immune system that trigger a cascade of antiviral responses in cells within minutes of infection. As such, the interferon pathway could significantly reduce the levels of virus initially produced by an infected individual.

"They are clinically viable therapeutic agents that have been studied for viruses like HIV-1 for years," says Santiago. "Here we looked at up to 17 different human interferons and found that some interferons, such as IFNalpha8, more strongly inhibited SARS-CoV-2. Importantly, later variants of the virus have developed significant resistance to their antiviral effects. For example, substantially more interferon would be needed to inhibit the omicron variant than the strains isolated during the earliest days of the pandemic."

The data suggests that COVID-19 clinical trials on interferons—dozens of which are listed in clinicaltrials.gov—may need to be interpreted based on which variants were circulating when the study was conducted. Researchers say that future work to decipher which of SARS-CoV-2's multitude of proteins might be evolving to confer interferon resistance may contribute in that direction.
 

Heliobas Disciple

TB Fanatic
(fair use applies)

COVID-19 may have increased UK doctors' willingness not to resuscitate the very sick and frail
by British Medical Journal
July 25, 2022

COVID-19 may have changed UK doctors' end-of-life decision-making, making them more willing to not resuscitate very sick and/or frail patients and raising the threshold for referral to intensive care, suggest the results of a snapshot survey published online in the Journal of Medical Ethics.

But the pandemic hasn't altered their views on euthanasia and physician-assisted dying, with around a third of respondents still strongly opposed to these policies, the responses show.

The COVID-19 pandemic transformed many aspects of clinical medicine, including end-of-life care, prompted by thousands more patients than usual requiring it, say the researchers.


They therefore wanted to find out if it has significantly changed the way in which doctors make end-of-life decisions, specifically with respect to "Do Not Attempt Cardio-Pulmonary Resuscitation" (DNACPR) and treatment escalation to intensive care.

The researchers chose these aspects of end-of-life care because of the controversy surrounding DNACPR decisions, partly prompted by an increase in cardiac arrests associated with COVID-19 infections and concerns about intensive care capacity, sparked by soaring demand during the pandemic.

The researchers also wanted to know if the pandemic had changed doctors' views on euthanasia and physician-assisted suicide as surveys on these issues by the British Medical Association (BMA) and the Royal Colleges of Physicians and General Practitioners had been carried out before it started.

The online survey was open to doctors of all grades and specialties between May and August 2021, when hospital admissions for COVID-19 in the UK were relatively low.

In all, 231 responses were received: 15 from foundation year 1 junior doctors (6.5%); 146 from senior junior doctors (SHOs) (63%); 42 from hospital specialty trainees or equivalent (18%); 24 from consultants or GPs (10.5%); and 4 others (2%).

With respect to DNACPR, which refers to the decision not to attempt to restart a patient's heart when it or breathing stops, over half the respondents were more willing to do this than they had been previously.

When the responses were weighted to represent the different medical grades in the NHS national workforce, the results were: "significantly less," 0%; "somewhat less," 2%; "same or unsure," 35%; "somewhat more," 41.5%; "significantly more," 13%; and "not applicable," 8.5%.

When asked about the contributory factors, the most frequently cited were: "likely futility of CPR," (88% pre-pandemic, 91% now); "co-existing conditions," (89% both pre-pandemic and now); and "patient wishes," (83.5% pre-pandemic, 80.5% now). "Advance care plans" and "quality of life" after resuscitation also received large vote-share.

The number of respondents who stated that patient age was a major factor informing their decision increased from 50.5% pre-pandemic to around 60%. And the proportion who cited a patient's frailty rose by 15% from 58% pre-pandemic to 73%.

But the biggest change in vote-share was "resource limitation," which increased from 2.5% to 22.5%.

When asked whether the thresholds for escalating patients to intensive care or providing palliative care had changed, the largest vote-share was the "same or unsure," 46% (weighted) for referral; 64.5% (weighted) for palliative care.

But a substantial minority said that now they had a higher threshold for referral to intensive care (22.5% weighted) and a lower threshold for palliation (18.5% weighted).

When it came to the legalization of euthanasia and physician assisted suicide, the responses showed that the pandemic has led to marginal but not statistically significant changes of opinion.

Nearly half (48%) were strongly or somewhat opposed to the legalization of euthanasia, 20% were neutral or unsure, and around a third were somewhat or strongly in favor before the pandemic. These proportions changed to 47%, 18%, and 35%, respectively.

Similarly, just over half (51%) said they had strongly or somewhat opposed the legalization of physician assisted suicide, 24% had been neutral or unsure, and 25% had been somewhat or strongly in favor. These proportions changed to 52%, 22%, and 26%, respectively.

The impetus to make more patients DNACPR, prompted by pressures of the pandemic, persisted among many clinicians even when COVID-19 hospital cases had returned to relatively low levels, note the researchers. The factors informing it were compatible with regulatory (GMC) ethical guidance—with the exception of limited resources.

"At the start of the pandemic, the BMA advised clinicians that in the event of NHS resources becoming unable to meet demand, resource allocation decisions should follow a utilitarian ethic.

"However, what is clear from our results is that for a significant proportion of clinicians, resource limitation continued to factor into clinical decision making even when pressures on NHS resources had returned to near-normal levels," they write.

The survey results also suggest that the pandemic has helped clinicians gain a greater understanding of the risks, burdens, and limitations of intensive care and had further educated them in the early recognition of dying patients, and the value of early palliative care, they add.

"What is yet to be determined is whether these changes will now stay the same indefinitely, revert back to pre-pandemic practices, or evolve even further," they conclude.
 

Heliobas Disciple

TB Fanatic
(fair use applies)

Hair and libido loss join fatigue and brain fog among wider list of Long COVID symptoms
by University of Birmingham
July 25, 2022

Long COVID sufferers have experienced a wider set of symptoms than previously thought including hair loss and sexual dysfunction, new research has found.

A study published in Nature Medicine today found that patients with a primary care record of infection with the virus that causes COVID-19 (SARS-CoV-2 coronavirus) reported 62 symptoms much more frequently 12 weeks after initial infection than those who hadn't contracted the virus.

Anonymised electronic health records of 2.4 million people in the UK were analyzed by researchers from the University of Birmingham alongside a team of clinicians and researchers across England, and was funded by the National Institute for Health and Care Research and UK Research and Innovation. The data taken between January 2020 and April 2021 comprised of 486,149 people with prior infection, and 1.9 million people with no indication of coronavirus infection after matching for other clinical diagnoses.

Using only non-hospitalized patients, the team of researchers were able to identify three categories of distinct symptoms reported by people with persistent health problems after infection.

Patterns of symptoms tended to be grouped into respiratory symptoms, mental health and cognitive problems, and then a broader range of symptoms. While the most common symptoms include anosmia (loss of sense of smell), shortness of breath, chest pain and fever; others include:
  • amnesia,
  • apraxia (inability to perform familiar movements or commands),
  • bowel incontinence,
  • erectile dysfunction,
  • hallucinations,
  • limb swelling
Dr. Shamil Haroon, Associate Clinical Professor in Public Health at the University of Birmingham is the senior author on the study. Dr. Haroon said:

"This research validates what patients have been telling clinicians and policy makers throughout the pandemic, that the symptoms of Long COVID are extremely broad and cannot be fully accounted for by other factors such as lifestyle risk factors or chronic health conditions.

"The symptoms we identified should help clinicians and clinical guideline developers to improve the assessment of patients with long-term effects from COVID-19, and to subsequently consider how this symptom burden can be best managed."

Patient partner and co-author of this study Jennifer Camaradou said:

"This study is instrumental in creating and adding further value to understanding the complexity and pathology of long COVID. It highlights the degree and diversity of expression of symptoms between different clusters. Patients with pre-existing health conditions will also welcome the additional analysis on risk factors."

As well as identifying a wider set of symptoms, the research team also found key demographic groups and behaviors which put people at increased risk of developing Long COVID.

The study suggests that females, younger people; or belonging to a black, mixed or other ethnic group are at greater risk of developing Long COVID. In addition, people from low socioeconomic backgrounds, smokers, people who are overweight or obese, as well as the presence of a wide range of health conditions were associated with reporting persistent symptoms.

Anuradhaa Subramanian, Research Fellow at the Institute of Applied Health Research, University of Birmingham and lead author of the paper said:

"Our data analyses of risk factors are of particular interest because it helps us to consider what could potentially be causing or contributing to Long COVID. We already know that certain modifiable traits such as smoking and obesity put people at increased risk of various diseases and conditions, including Long COVID. However, others such as biological sex and ethnicity also appear to be important.

"Women are for example more likely to experience autoimmune diseases. Seeing the increased likelihood of women having Long COVID in our study increases our interest in investigating whether autoimmunity or other causes may explain the increased risk in women. These observations will help to further narrow the focus on factors to investigate that may be causing these persistent symptoms after an infection, and how we can help patients who are experiencing them."

Patient records for 2.3m people enabled the research team to capture post SARS-CoV-2 infections at a unique point in the global pandemic. The study focuses on the first phase of the pandemic in the UK between January 2020 and April 2021 and provided the team with an opportunity to compare meaningful numbers of people who had coronavirus infections alongside a control group of uninfected people.

The interdisciplinary team involved epidemiologists, clinicians, data scientists, statisticians, and patients to decode electronic health records to accurately capture persistent symptoms experienced after infection.

Dr. Shamil Haroon said: "The results are both a testament to the opportunities that these public health datasets provide, and to the power of collaborative work to provide much needed evidence around the experiences of many people who have been affected by persistent symptoms after infection with the coronavirus. I hope our research will also further validate the voices of patients and involvement groups and provide an approach to support healthcare responses to new and emerging diseases."
 

Heliobas Disciple

TB Fanatic
(fair use applies)

A third COVID-19 booster is crucial to identifying and fighting new variants
by University of Surrey
July 25, 2022

Twenty different COVID-19 variants were effectively identified and neutralized after a third booster, according to the new study for which the University of Surrey provided the crucial antigenic map of variants of concern.

While the study's results suggested that immunity decreases 20 weeks after vaccination, a third booster (of the Pfizer-BioNTech vaccine, in the case of this study) helped the immune system to identify and neutralize the 20 different variants.

The antigenic map allowed the team to identify and measure how each variant impacted the immune system.

Dr. Daniel Horton, co-author of the study and Reader in Veterinary Virology at the University of Surrey, said: "The emergence of this disease and its disruptive and deadly impact on our day-to-day lives demonstrates how crucial it is for the scientific community to work together to identify and characterize infectious diseases quickly.

"The University of Surrey's contribution to this study through the mapping of the various variants is itself part of a landmark €90 million collaborative effort to tackle zoonotic diseases in Europe, reflecting our focus on understanding the inextricable links between the health of animals, humans and, indeed, the planet we all share."

The Pirbright Institute led this collaborative study with scientists from the University of Surrey, Imperial College in London and the U.K. Health Security Agency (UKHSA) to understand the immune response of individuals aged 70–89 who had received the Pfizer-BioNTech vaccine.

This vaccine works by triggering the immune system to create Y-shaped proteins, known as antibodies, that can stick to the spike proteins which are found on the surface of the coronavirus. If a person is infected with SARS-CoV-2, the antibodies bind the spike proteins preventing the virus from attaching to and entering the human cell, therefore helping to protect from severe disease. Antibodies also act as a beacon to alert the immune system to help fight the infection.

Dr. Dalan Bailey, Head of the Viral Glycoproteins group at Pirbright, said: "Understanding how the levels of neutralizing antibodies relate to a well-defined immune response will be an important step in understanding how the immune system responds to SARS-CoV-2 and could also help in the management of COVID-19.

"This information could help us to understand whether the risk of breakthrough infections, hospitalization and death is increased by waning immunity or new variants. Research comparing immune responses to different SARS-CoV-2 variants and understanding the role of different mutations is vital in the management of the COVID-19 pandemic and in predicting the outcome of new variants."

The research was published in Nature Microbiology.
 

Heliobas Disciple

TB Fanatic
(fair use applies)

Researchers pinpoint genetic variations that might sway course of COVID-19
by Mayo Clinic
July 25, 2022

Researchers at Mayo Clinic's Center for Individualized Medicine have discovered key human genomic signatures that could help explain why COVID-19 is severe in some people and mild in others. After analyzing volumes of diverse worldwide DNA sequence data, the scientists identified mutations in two human proteins that might sway the course of SARS-CoV-2—the virus responsible for COVID-19.

Their study reveals that variants in the genes for ACE2 and TMPRESS2 can lead to an increase or decrease in protein expression. An increase in protein expression might result in elevated COVID-19 susceptibility and severity, while a decrease might have a protective effect against the virus. Proteins play many critical roles in the body. In this case, ACE2 and TMPRESS2 provide critical entry points for SARS-CoV-2 to invade and infect human cells.

The study findings, published in Human Molecular Genetics, suggest a potential new diagnostic approach that is based on variation in the host cells rather than the constantly evolving virus itself.

"COVID-19 is a master of frequency in changing the sequences of its genes, but that only tells half of the story. Our findings suggest that the virus's interaction with proteins encoded by the human genome may also be a contributor to a person's disease outcome," says Lingxin Zhang, Ph.D., the lead author of the study and a researcher in the Pharmacogenomics Program of the Center for Individualized Medicine.

"These results can now be applied to DNA sequence data for patients infected with SARS-CoV-2 to potentially determine the degree of susceptibility to the disease," Dr. Zhang adds. "I hope this methodology can be expanded for other genes involved in COVID-19, and that scientists and clinicians across the world can use this information to help their patients."

For the study, Dr. Zhang and her team delved deep into the DNA sequencing data of nearly 71,000 people worldwide, including nearly 30,000 racial and ethnic minorities, to identify sequence variants in the ACE2 and TMPRESS2 genes. The team then analyzed hundreds of protein variants encoded by those genes and identified variant genes that generated high and low expression levels. To do that, Dr. Zhang engineered cells capable of expressing the protein variants, and then, using color-coding, she and her team analyzed the variants to see which were more or less stable.

The study used nearly a million generated cells and produced billions of data points, which the team analyzed using a series of technologies, including cell sorting, modern genomics, high throughput DNA sequencing and a computer algorithm.

"To our knowledge, it's the first time anyone has applied this approach to COVID-19," says Richard Weinshilboum, M.D., co-author of the study and a pharmacologist in the Center for Individualized Medicine, and Department of Molecular Pharmacology and Experimental Therapeutics. "This work would not have been possible without the dramatic advances that have occurred in DNA sequencing, joined together with parallel advances in our ability to test the functional and medical implications of individual variations in DNA sequence—and as a result—of individual variation in the proteins encoded by our genes."

Dr. Weinshilboum says the study also was made possible by the large quantity of human DNA sequence information that is now publicly available—with the proviso that those data must be carefully protected and must have their use reviewed and approved to avoid any possible violation of privacy.

As of July 11, 2022, more than 6.3 million people worldwide have died from COVID-19 since the start of the pandemic.
 

Heliobas Disciple

TB Fanatic
(fair use applies)

lying with statistics: US all cause deaths edition
crossing out cross correlations and getting to the meat of the matter
el gato malo
19 hr ago

it has recently come into vogue to try to use US state scale data to prove that covid vaccines have all cause mortality benefit.

much of this appears misleading and there looks to be a lot of confusion about what some of this data means and how to read it, so it seemed like a good time for another edition of “stats with cats” to see if we can’t get to the bottom of it.

let’s look:

this argument, an example of which is made here by associate econ professor micah pollak, rests on correlations from data.

it’s precisely the kind of argument that looks very compelling at first blush but is, in fact, complete fallacy. (in fact, several fallacies)

can you spot the errors?

Image
if you said “correlation is not causality” that’s a good start.

if you said “there is no base rate or control group and this dataset is neither randomized nor matched by risk factor” go to the head of the class.

the problem with correlation is that it cannot, by itself, prove anything. any econ professor should know this so micah is either being extremely sloppy or seeking to mislead.

there are about 100 relevant cross correlations: age, obesity, diabetes, access to medical care, etc. this has enormous effects on outcomes.

and “excess deaths” as used by micah is using a pre-covid baseline to assess a post covid world in which all these effects pertain.

it’s like using a nighttime baseline to assess daytime warming.

i made this chart (full calculation and data HERE) about a year ago.

overall, presence of comorbidity is associated with a greater than 10X expression of death as an outcome.
this has long been known.



and there is strong clustering of high risk factor prevalence and low vaccine uptake.

this becomes incredibly obvious when you pull the correlations.

here is US states by vaxx rate plotted against obesity rate.

notice anything?



this R2 is even higher than micah’s.

you can predict 52% of vaxx rate by obesity rate.

obesity rate also correlates to higher covid deaths and to about 20 other risk factors like diabetes and hypertension.
here’s another telling cross correlation (and an odd omission for an economist): wealth.

similarly, the life disruptions and career damage have been much higher in the working poor than the laptop classes. those with less income also tend to have less access to medical care.

and income level predicts vaxx strongly.



and, as the cross correlation with these two variables is strong, we get into very tough territory to tease a signal out of using a method as unsophisticated as simple correlation on vaccines and all cause deaths.

many of the least vaxxed are also the most obese and poorest.

we’re not comparing anything remotely resembling like to like.

the analysis presented by micah might be appropriate for a well controlled, randomized trial, but this ain’t that.

there is obviously quite a lot more going on here than just jab variance.



diabetes (probably the worst of the covid risk factors) in particular is known to have gotten seriously out of control during covid and has strong cross correlation to obesity and state income level. (.49 and .34 R2 respectively)

these are strong relationships with known or strong reason to presume high causal effect.

to ignore them seems like an omission that will irretrievably taint this analysis.

this is telling you that professor pollak’s claims are almost certainly spurious.

it’s telling you that neither we nor he can have any idea what he is measuring.


(also, as many of these R2’s are higher than his 0.4, it points the the possibility that on a like to like basis, the relationship micah presents may actually invert)

this is why you have to be VERY careful trying to use correlation to prove causality in non-balanced and non-randomized data. (it’s also why the RCT structure exists: to control for and root out exogenous and extraneous cross correlations like this.)

addendum: a reader points out that the timeframe chosen by micah is a significant cherry pick and i think this is correct.​
it starts in june 2021, just as the peak southern seasons for covid commence and runs to now. this will mean that the southern states (which are lower vaxx rate) will contain 2 peak covid seasons vs only one for the highly vaxxed north. failure to normalize this series for seasonal expression is a severe issue.
this badly salts the sample.​
thanks to t coddington for pointing this out.


so how COULD we go about assessing this?

we need a control group and the best control group to use in a case like this is the states themselves, or better still, the counties so that we can get better granularity.

their ages, demographics, incomes, seasonality, etc all remain fairly constant.

before doing a huge pile of work on such issues, it always pays to first see if someone else has already done it and as fortune would have it, they had.

first we go to this wonderful analysis by longtime gatopal™ and idea vetting amigo ethical skeptic whom i suspect many of you know.

here’s what a real analysis of this topic looks like.

(spoiler alert, it’s not supportive of the “vaccines saved lives” thesis.)

Image

the premise is simple: vaccine effects cannot travel back in time so if we take 2020 and plot it we can get a baseline by county for the US covid deaths. as can be readily seen (dashed line), they were already much lower in the counties that wound up high vaxx even before the vaccine was released. (and a lot of the very lowest vaxx counties are likely affected by data artifacts of low overall reporting)

so that is our baseline. it aligns quite well with the expectation generated from the obesity and income dispersions.
the solid line is the post vaccination period. two very noticeable things emerge from that:
  1. the covid deaths outcomes are worse post vaccine
  2. the extent of it being worse rises as vaxx rates increase (this can be seen by the widening distance between the two curves)
micah will doubtless try to argue that this is because they were “compliant” and therefore did better because they masked up, locked down, etc. but this is a bad branch to climb out upon as there is no evidence that any of those mitigations worked and quite a lot that they did not so this argument relies both upon the presumption of a disproven premise, fails to account for intrinsic factors like obesity, wealth, and underlying health that are clearly material, and if true, would undermine his own vaccine claims in any event.

so he’s into a real zugzwang there.

now, one might argue that just mapping to covid deaths is inapt because we’re looking for an all cause deaths signal. this is not without merit, so let’s tag in another gatopal™ our old friendben who produced this chart looking at peak covid seasons (q4-q1) in 2020-1 (pre vaxx) shown as A and 2021-2 (post vaxx) shown as B.

Image

but where this gets really interesting is panel C which looks at the year over year change by state from A to B.

this again uses states as their own controls and therefore takes out seasonal and demographic signals to hone in on vaccines as a variable. it’s just a “before and after” analysis.

and this inverts pollak’s claims.

high vaxx is having worse all cause mortality relative to prior year than low vaxx which not only contradicts the “vaccines helped” claim but may well invert it. it also finds alignment with ethical skeptic’s chart and so the mosaic effect begins to pile up.

we find further alignment with the raw RCT data which helps us avoid the spurious associative traps and false correlations that plague data mining.


Image

the three together are deeply damaging to the idea that vaccines are saving lives and i have a suspicion that the outcome variance here will be even worse in Q2 and Q3 2022 because by vaccine driven viral evolution looks to making the BA variants of omicron into highly vaccine advantaged strains that are upping hospital rates vs a year ago in highly vaxxed places and making the vaccinated into superspreaders.

that data is starting to look more than a little ominous.

compare last year to this year:



and it looks like case counts are up so much vs a year ago that it’s starting to swamp the milder outcomes of omicron.

that which is half as serious but 4X as prevalent still leads to twice the deaths.


the data on covid is low quality and notoriously a bit of a mess. it’s also incredibly complex and riddled with simpson’s paradoxes, cross correlations, and seasonal issues just to name a few.

this is difficult data in which to be a tourist, but even so, making the sort of rudimentary foundational data handling error that “assuming one simple correlation proves causality without establishing a baseline or controlling for exogenous variables” is not one an “expert” ought be making or encouraging others to make.

no only is it bad methodology and does it fail to fit with the broader data mosaic, but when you do control for the underlying factors claims of VE for ACM not only disappear, they look to invert.

so, i think we can consign such uncorrected correlation driven claims to the epidemiological rubbish heap and move on.

thanks once more for shopping
 

Heliobas Disciple

TB Fanatic
(fair use applies)

Parents are pulling back on COVID-19 vaccines in children under 5 years of age, thank GOD & hopefully this stays same and they balk completely! Parents MUST say NO, under NO condition for healthy kids
Natural killer cells (NK) of innate immune system is the rate limiting step, critical component of innate immune system in young children can be subverted by the COVID injections; the outcome DEATH!
Dr. Paul Alexander
12 hr ago

Mass vaccination roll-outs employing a sub-optimal vaccine (such as the COVID vaccines) and then injecting across all age groups, and into a pandemic with massive infectious pressure (circulating virus) and a highly mutable and highly infectious respiratory virus can only result in selection pressure and the selection of infectious variant after infectious variant, that are resistant to the vaccinal antibodies and as such will be viral immune escape. The mass vaccination will only cause this pandemic to keep going for 100 more years and the sub-optimal non-neutralizing vaccinal antibodies are subverting, outcompeting the innate antibodies from binding to the live virus (virus that is circulating) and as such, not being trained. If they are not trained and instructed in childhood, they cannot educate the innate immune system potent effector cells such as the natural killer (NK) cells whose job is to clear out virus, foreign compounds, and to learn how to differentiate self from non-self of the child. If the NK cells cannot attain their functional capacity, then children will be at risk for auto-immune disease up to death.

Thus parents are giving their child a gift to resist these COVID injections. They must stave this off for the innate immune system of children must be allowed to train in the prescribed window of opportunity.
  • ‘As of July 20, approximately 544,000 children under the age of 5 had received at least one COVID-19 vaccine dose. This represents 2.8% of the approximately 19 million children in this age group. At a similar point in their vaccine roll-out, more than 5.3 million children ages 5-11 (18.5% of 5-11 year-olds) had received their first dose. (See Figure 1).


SOURCE:

COVID-19 Vaccination Rates Among Children Under 5 Have Peaked and Are Decreasing Just Weeks Into Their Eligibility
 

Heliobas Disciple

TB Fanatic
(fair use applies)

Accidental IV injection is real: Ever heard of "Tren Cough"? Bodybuilders regularly suffer this adverse event after steroid injections
IM Injection Safety Myth - "Tren Cough" is the proof that injecting in the muscle without aspirating carries significant risk of hitting a blood vessel with devastating consequences: a 5% chance!
Marc Girardot
Jul 24

For almost a year, I have been adamantly stating vaccine injuries are tied to accidental intravenous injections. “Tren cough” is the evidence I have been looking for. It proves that accidental intravenous injection are a significant reality, a reality that isn’t minute contrary to what the medical community thinks. This widely-known evidence ascertains further the Bolus theory that I have developed throughout my articles these past few months.

A big thanks to Eric for reaching out, and making me aware of “Tren cough”.


The more I age, the more I look forward to open debates and diversity of perspectives. It sounds like an overused narrative, but there’s nothing better than a good old fashion discussion to connect the dots. Here’s my story:

Last Wednesday, I had scheduled a Zoom call with one of my readers, Eric, who wanted me to write a piece on Autophagy. As often in a friendly open conversation we ended somewhere else altogether. Eric is a fitness entrepreneur in New York, a former bodybuilder and actor. Evidently, he comes with a rich and diverse experience I have no idea about … The Internet can’t really solve that gap. Only a human interaction can.

Eric is smart and has an inquisitive mind. So here we were chatting away on a variety of COVID topics, on his wife’s possible mask-induced pneumonia, on mucosal immunity … when we finally came to our defining moment around my “Bolus” theory. Eric interjected with a lot of confidence:

- “Of course, intravenous injections are common when you inject in the muscle! Do you know of “Tren cough”?

Not being into bodybuilding at all, I must admit I had no idea what he was talking about. Eric went on to explain that professional bodybuilders regularly inject themselves with a steroid called Trenbolone (Tren). The injection is intramuscular in the quadriceps, the deltoid or the glutes1 muscles. Apparently immediately after a Tren injection, it is not uncommon for inexperienced bodybuilders to get Tren cough. Tren Cough is a dry cough that is typically experienced immediately after the steroid jab. It sometimes can be quite scary as breathing becomes very difficult.

Here is a vivid description of the experience I found on the Internet:

“(I) Finished the shot, got my pants up, tasted the tren in my mouth and a cough started. Then my chest locked up. I couldn't breathe except to cough. I fell to the floor, was bucking as my whole body was dealing with what fell like my lungs had collapsed and my body was on a permanent coughing fit. I groaned out to my girlfriend who eventually came. I was unable to breathe a real breath for the entire episode which lasted what felt like an hour but was really about 2.5-3 mins. Still too long to not be able to breathe. She almost called 911 I was sweating buckets, tears running down my face. Eventually it all passed.”

Given these jabs are self-injected and their effects are instantaneous, there was never any doubt to the bodybuilding community as to the direct causality: an accidental direct injection into a blood vessel. As these injection are quite regular2, experienced bodybuilders have come to understand that occasionally the product is delivered directly into a small vein, and the products ends up in a concentrated form in the lungs where its vasoconstrictive effects causes these symptoms.


Adapted from EliteFitness video

Experienced bodybuilders know they should aspirate to check for blood, the sign they’ve hit a vessel, and should pull out to avoid “Tren cough”. Researchers have documented accidents as you can see below.



Click to document

This is very much aligned with the description that many vaccine injured have testified about: a taste in the mouth immediately after the shot, which can only mean the product was injected into the blood. The taste might be different, “spicy” for the Tren, “metal-like” for the vaccines, but it is the evidence that in both cases the product was directly delivered inside a blood vessel, however small it might be.

How Frequent is “Tren cough”?

In other words: How frequent are accidental intravenous injections?


Despite the evidence, many friends, readers and Team Reality members have been confidently discounting the possibility of inadvertent intravenous injections. Most simply stating they had been injecting for decades and had never hit a vein (not sure how they’d know?), throwing numbers like 1 in 10,000. Others probably wishing for a more intricate microbiological mechanism of harm, imagine a root cause more worthy of their qualifications. A stupid intravenous injection takes away all the intellectual fun, I get that. But safety and science should probably come first…

In my eyes, the physiology of the muscle makes it a mathematical certainty that blindly inserting a needle carries a significant risk of hitting a blood vessel. Cells after all need blood to survive. And the frustrating argument of authority “Have you ever injected a vaccine in a muscle, Marc?” - that I have been told so many times to respectfully shut me up - doesn’t change that fact.

Like urban areas, muscles need to dedicate a significant amount of their volume to their supply chain, there’s no escaping that logic. A study in the US highlighted that roads take up 18% of urban areas. That translates roughly to 7% in a 3D setting, a ratio of 1 to14. Nature is more optimised than our cities will ever be, but still not by a factor of 10, possibly 25-50%. So the odds I have been told of 1 to 10,000, or even 1 to 2,000, have to be widely exaggerated. Reality is probably more in the region of 1 in 20-30.

An Italian study for another less aggressive steroid found 2%. That’s 1 in 50 with aspiration and a product less detectable. So it’s reasonable to think that the probability is higher when one doesn’t aspire. Pr. Høiby suggested the aspiration technique reduces misplaced needles 60%.

This suggests accidental intravenous injection happens in 5% of cases when not aspirating! 1 chance out of 20…

On those grounds, people who are taking their 4th injection have a 20% chance of being harmed by the vaccine. One wonders why so many authorities have decided against following the lead of Denmark and Hong Kong. More importantly when designing the injection protocols why weren’t they aware of the best-in-class protocol designed by bodybuilders?

Doctors and WHO can learn a lot from Bodybuilders

It’s fascinating to witness the difference in reaction between:
  1. a skin-in-the-game community with high stakes involving “their own lives”: the bodybuilders, on one side; and
  2. a compliant and oblivious community whose lives are not impacted by the shot: the medical community.
In other words, if doctors and nurses self-injected and had experienced “Tren cough”, they’d likely have adopted similar protocols to the ones designed by the bodybuilding community, and would have avoided most of the dramatic adverse effects these past 19 months.

Here are a few recommendations I have collected for your doctor, or for the WHO:
  1. Use a different needle to inject the liquid than the one used to draw it from the vial. They are of different length apparently. Frankly, not sure how that can play a role, one way or the other. It simply makes sense in terms of purpose of the needle, but without further analysis, it could go both ways.
  2. Insert the needle slowly to potentially push aside vessel instead of piercing through them. We’ve been seeing the opposite, rapid needle insertion, just about everywhere, just to avoid pain. Not very smart.
  3. Dilute further the product: This is an excellent idea: The more diluted, the safer. Say you dilute the vaccine in twice the volume of saline, then the transfection3 potential would be reduced by roughly 40%.
  4. Aspire to test for blood (surprise, they also aspirate!): pull out if positive to avoid injecting directly into the bloodstream. I think I have beat that one to death already. We know Denmark, Hong Kong and Germany ended up reinstating the “aspiration technique”… Still wonder what the WHO is doing frankly?! Very indicative that the purpose of their leadership isn’t about safety to say the least. Else they would have looked at Germany, and followed suite, even if late in the game.
  5. Inject the product very slowly - in other words, “Avoid a bolus! ”: Typically, IV injected drugs are injected over one minute. Can you imagine the difference…
In other words, bodybuilders have come up with 4 different mitigation techniques, where WHO and the medical community have zero ! …

We need to flatten a curve: the Bolus curve!

Avoid accidental intravenous insertions.

Avoid rapidly pushing on the seringue plunger.


It is frightening to realise how opposed the WHO injection protocol is to the bodybuilders’ evidence-based protocol. As if a protocol to inject the entire humanity had been designed by inexperienced professionals, entirely retrenched from reality…

In conclusion, all the building blocks of my theory are now proven to be real and certain.

  • Accidental intravenous injections are a physiological and mathematical certainty when injecting massively a population intravenously and not putting in place mitigation measures.
  • Bolus creation and concentrated transfection is pharmaco-dynamic certainty: Instantaneous push on the plunger inevitably creates a Bolus when injected in the blood as proven by many studies and highlighted by multiple IV delivered drugs protocols.
  • The Endothelium as the main transfected area is a physical certainty: Transfection being more complex than people think, only where the pressure or/and the topology is favorable (capillaries) will transfection occur. The circulatory system is the only location whereby the conditions are conducive to effective transfection.

  • Transfected cells destruction is also an immunological certainty: Be it via Natural Killers cells, or T-cells, multiple studies have demonstrated the immune system predictably is doing its job of scuttling any apparently compromised cells.
  • When the endothelium is damaged, coagulants are a biological certainty: If thousands of adjacent endothelial cells are destroyed simultaneously in the aorta or in arteries, coagulants trying to clog the hole and stop the bleeding will be carried downstream by the flow, and will clog capillaries and veins downstream. That’s inevitable. Strokes, thrombosis, purpura, necrosis, organ failure will entail.
  • In less severe cases, increased permeability of blood-tissue endothelial barriers is evolutionary certainty, be it transient or permanent: Evolution has granted us unique healing capabilities, but the loss of massive cellular areas often comes with a loss of function. The homeostasis is disrupted beyond perfect repair. For example, when skin is burnt, it can heal but will loose flexibility, capacity to sweat, etc…the same is bound to happen when our immune cells ravage through our endothelial walls.
This is all perfectly consistent with the wide variety adverse effects witnessed throughout the world. It is also congruent with past massive vaccination campaigns that were stopped early. But more importantly it is also in line with less visible damage being done by other transfecting vaccines (read all attenuated virus vaccines, notable MMR).

There is no doubt in my mind that over-centralisation of Public Health is a recipe for disaster. Technocratic doctors, retrenched away from the field, hidden from the realities of this world in Geneva, deciding for the world could only lead - and has lead -to many disasters already.

May be a few bodybuilders can go a teach these guys how to properly inject? …

Love Marc.


1 i.e. in the buttocks

2 Every day for Trenbolone acetate, every week for Trenbolone enanthate

3 Transfection is the process by which foreign material in inserted into a cell, notably an antigen, DNA or mRNA.
 

Heliobas Disciple

TB Fanatic
(fair use applies)

JUST IN - Normalizing VAIDS: China To Start Treating COVID Patients With Domestically Produced HIV Drug, Reuters Reports
2nd Smartest Guy in the World
16 hr ago

China did not deploy Modified mRNA slow kill bioweapon injections in their country. But anything that delivers and/or induces spike proteins will result in VAIDS.

BEIJING, July 25 (Reuters) - China on Monday gave conditional approval to domestic firm Genuine Biotech's Azvudine pill to treat certain adult patients with COVID-19, adding another oral treatment option against the coronavirus.

The question here is does this policy change reflect a genuine need for VAIDS drugs, or is this akin to Chinese citizens allegedly dropped dead on streets due to “COVID”? In other words, is this the CCP telegraphing the normalization of DEATHVAX™ AE’s in the form of VAIDS in order to further push the One World Government agenda ahead of ever more draconian reinstated lockdowns in the fall, thus further dismantling America en route to the Great Reset?

Here is a research study from last year, entitled Acute HIV infection syndrome mimicking COVID-19 vaccination side effects: a case report.

Background
Symptoms of primary HIV infection, including fever, rash, and headache, are nonspecific and are often described as flu-like. COVID-19 vaccination side effects, such as fever, which occur in up to 10% of people following COVID-19 vaccination, can make the diagnosis of acute HIV infection even more challenging.

The CCP is running cover for the current burgeoning VAIDS pandemic that will be in turn whitewashed as the imminent PSYOP-22 “pandemic” is rolled out.

The study concluded:

Given the similarity of symptoms, including fatigue, fever, erythema, headache, and drowsiness, primary HIV infections can easily be overlooked, and symptoms of acute HIV infection can be falsely attributed to vaccine side effects. […]
In conclusion, this case report highlights the possibility of symptoms and test results in early HIV infection being misinterpreted due to concurrent COVID-19 vaccination and the diagnostic gap in early infections, making it easy to falsely attribute symptoms to vaccine-associated side effects.
Falsely attributing “HIV infection” to DEATHVAX™ side effects is what this particular reality inversion messaging is attempting to impart. How do we know this? Here are the admitted conflicts of interest for this study and it’s paid of researchers:

Christoph Spinner reports grants, personal fees, and non-financial support from AbbVie; grants, personal fees, and non-financial support from Apeiron; grants, personal fees from B. Braun Melsungen, grants from Cepheid, personal fees from Formycon, grants, personal fees, and non-financial support from Gilead Sciences; grants and personal fees from Eli Lilly; grants, personal fees, and non-financial support from Janssen-Cilag; personal fees from Molecular partners, grants, personal fees, and non-financial support from GSK/ViiV Healthcare; grants, personal fees, and non-financial support from MSD, outside the submitted work. Simon Weidlich reports personal fees and non-financial support from Gilead Sciences and Janssen-Cilag. No additional competing interests by any authors of this article.

Officially, funding for this study was provided by Projekt DEAL, which is comprised of university assets funded by BigPharma.

Back to the Reuters article, where Genuine Biotech using BigPharma drug patents essentially admits to faking their trial results by not providing detailed readings:

In a late-stage clinical trial, 40.4% of patients taking Azvudine showed improvement in symptoms seven days after first taking the drug, compared with 10.9% in the control group, Henan province-based Genuine Biotech said in a statement earlier this month, without providing detailed readings.

A fraudulent clinical trial a la Pfizer’s fraudulent claims and trials that the wholly captured and criminal FDA attempted to disappear for 75 years.

Expect the same “dynamic PSYOP-22 zero” CCP policy to be implemented in the West this fall as VAIDS and all-cause mortality continue to surge.
 

Heliobas Disciple

TB Fanatic
(fair use applies)

Lockdowns causing Hepatitis in Children; China approves HIV drug for use in Covid and School Unions on the march again
Today's Covid news.
NE - nakedemperor.substack.com
18 hr ago

So they think they have found the likely cause of the mystery hepatitis outbreak in children. And surprise surprise, the cause was…Lockdowns.

A report by the BBC (which heavily promoted lockdowns) said “two teams of researchers, from London and Glasgow, say infants exposed later than normal - because of Covid restrictions - missed out on some early immunity to: adenovirus, which normally causes colds and stomach upsets and adeno-associated virus two, which normally causes no illness and requires a coinfecting "helper" virus - such as adenovirus - to replicate.”

Covid or vaccines were ruled out as a cause but I guess there is still the theory of shedding. Whilst children of this age were not vaccinated, some have speculated that spike protein shedding from vaccinated parents may have been the cause. There has been no evidence either way to support this however.

I would prefer to stick with what we do know and that is that lockdowns are extremely damaging. The report says that experts are hopeful cases are becoming fewer but are still on the alert for new ones. Great, if new cases disappear but “experts” got us into this mess in the first place.

The BBC article says more than 1,000 children (many under five) have been affected and focusses on one child who needed an urgent liver transplant. Fortunately, he is recovering but he has needed a liver transplant and will need to take immunosuppressant drugs for the rest of his life. Moreover, his Mum ended up in intensive care after she was going to donate part of her liver but ended up reacting to the drugs.

The Mum is quoted as saying “There is something really heartbreaking about that because you go along following the rules, do what you are supposed to do to protect people that are vulnerable and then, in some horrible roundabout way, your own child has become more vulnerable because you did what you were supposed to do.”

In a highly complex society, every tiny change can have massive consequences. Especially with things that we don’t fully understand, such as viruses, even if we like to pretend we do. Not only did “experts” not consider the unintended consequences that could and would occur due to lockdowns (publicly at least) but they actively supressed any discussion on the topic. The mainstream media was complicit by again not allowing these discussions to take place. They should hang their heads in shame and ensure it never happens again.


To further the lab-leak “conspiracy theories”, today China has approved the drug Azvudine for Covid-19 patients. Why is this connected to lab-leak theories? Well it may not be but this is a drug which was designed for HIV-1 patients. And what has HIV-1 got to do with Covid? According to some, the spike protein in SARS-CoV-2 contains 4 inserts which are found in HIV-1.

There is probably a simple answer as to why a HIV drug can be used for Covid but I still think it needs questioning. You could argue that this is just a repurposed drug, like Ivermectin, and Covid is not river blindness just because a river blindness drug works on Covid. But still, I would like to understand why.

Post any explanation in the comments below.


And finally for now, in the UK, school unions are once again ramping up the fear in preparation for winter. They have written to the Secretary of State asking for, amongst other things:

  • a public health messaging campaign on vaccination given the very low rates of childhood vaccination;
  • updated guidance on face coverings;
  • the reinstatement of Covid risk assessments.
Image

Image

They just won’t give up.
 

Heliobas Disciple

TB Fanatic
(fair use applies)

UK SAGE’s Susan Michie Promoted to Lead WHO’s Nudge Unit
Michael P Senger
12 hr ago

Susan Michie, a 40-year member of the British Communist Party and a leading participant in the UK Government’s Scientific Pandemic Insights group on Behaviour (SPI-B) “nudge unit” to drive consent for Covid mandates, has been promoted to Chair of the WHO’s Technical Advisory Group for Behavioural Insights and Science for Health.

Last year, when asked how long Britain’s Covid containment measures should last, Michie responded that they should last forever: “Test, trace and isolate system, border controls are really essential…social distancing…wearing face masks…we’ll need to keep these going in the long term…I think forever.”

On Good Morning Britain, when asked whether her membership in the Communist Party might inform her draconian policy preferences, Michie expressed outrage: “I’ve come on your program as a scientist… You don’t ask other scientists about politics, so I’m very happy to speak about science, which is what my job is, and to limit it to that.” Michie is a behavioural psychologist with no background in epidemiology or infectious disease.

Maajid أبو عمّار @MaajidNawaz
A 40-year member of the Communist Party of Britain - Susan Michie - has just been appointed Chair of WHO’s Technical Advisory Group for Behavioural Insights and Science for Health: https://t.co/r8xWJcsLyh
UCL Psych & Lang Sci @UCLPALS
Many congratulations to Professor Susan Michie @SusanMichie for being appointed Chair of WHO’s Technical Advisory Group for Behavioural Insights and Science for Health! @WHO @UCLBehaveChange @UCLBrainScience https://t.co/y3oQP2jqJ4
July 25th 2022
607 Retweets1,003 Likes


The timing is ironic, as BBC reports that a team of UK scientists just concluded that a recent surge in cases of child hepatitis was attributable to lockdowns such as those Michie advocated, and had no connection to the virus. “Infants exposed later than normal—because of Covid restrictions—missed out on some early immunity… Scientists have ruled out any connection with coronavirus.”

Michie’s promotion also comes just as WHO Director Tedros Adhanom unilaterally declared Monkeypox a Public Health Emergency of International Concern—just weeks after the world’s first-ever global outbreak of Monkeypox happened to appear in the exact week of the exact month predicted by an international biosecurity simulation a year prior.

Disclose.tv @disclosetv
NOW - WHO's Tedros: "I have decided that the global #monkeypox outbreak represents a public health emergency of international concern."

July 23rd 2022
3,935 Retweets8,690 Likes


As the free world continues to be trolled by its ruling class, it’s clear that the World Health cartel certainly knows how to reward its highest performers.



 

Zoner

Veteran Member
This is the video that the article above this is talking about. I started to watch it and then started to take notes because it was that good a video. Yes it's Fauci but they ask him tough questions, especially the woman. I was cheering her on, and Fauci got touchy back at her so if you have time, watch.

View: https://www.youtube.com/watch?v=WXrWTkEjDtQ
Dr. Anthony Fauci EXCLUSIVE: MORE Stringent Response Had Fauci Known Then What He Knows Now
20 min 10 sec

Jul 25, 2022
The Hill

Dr. Anthony Fauci, the director of the National Institute of Allergy and Infectious Diseases, weighs in on COVID related decisions made since the start of the pandemic.

My notes, started a few minutes in when I realized this was a great video: He says that masks would have done differently had he known then what he knows now. That KN95 would've been important, and they are very good of acquisition of and transmission of infection. Right now he is clear that masks do work but has to be high quality and well fit. N95 or KN95. Question: Why was mass antibody testing never part of covid response and why was natural immunity ever taken seriously and do you regret that? Says always aware if you get infected you have a degree of protection against reinfection. Clear now (not then) that the protection of natural infection and from vaccines wanes over time. Tells questioner her question wasn't fair! (unbelievable). You have to be open minded to deal what dealing with in real world is elusive target. Other journalist says I thought we're open to question and debate. Do you hear that criticism? Brings up monkeypox and that they're not ready for it. Same errors that were made in early days of covid. Says he always had/has an open mind and takes from the community. (unbelievable again). Takes criticism seriously (right after he told off the woman questioner). Woman again -questions school closing was a disaster (you have to watch just to watch this woman, she's great, and getting under his skin which you can tell by how he answers her). Would he recommend locking down schools again. He denies he said they should lock down schools. (someone needs to fact check that). Closing schools should be a last resort (also needs to be fact checked if he said that). Asking about lab leak and gain of function research - what are benefits of that type of research. We didn't get vaccines from that so it didn't help, why do it? He says they are using gain of function wrong. You have to examine in the field and need understanding and protecting. we put guardrails up. outside committees. they came up with them for bat viruses and viruses from the environment with sars cov2 and mers. Followed those guardrails. misconception about GoF as a category as opposed to a certain situation whether the benefit outweighs risk and the risks are under guardrails. He makes one point --research funded by NIH, the viruses studied there (people interrupt and he never gets to say this) - the viruses studied and published, any card carrying virologist who knows about viral evolution would tell you it's impossible for those viruses to turn into SarsCov2 by accident or on purpose. Impossible. But research funded by NIH, people make an inappropriate conflation with those experiments and sarcov2. Does he keep an open minded about funding chinese scientists - could a lab leak be a possibility? of course, he keeps an open eye. See what was studied and published though and still say if you keep an open mind the most likely evolution is a natural jumping of species. Have to go with the data.
Thanks HD. Fauci has always been a tool and he knows how to lie.
 

Heliobas Disciple

TB Fanatic
I am posting this becuase it is the news story of the day. It will be debunked in a substack to be posted when I post those.

(fair use applies)

New studies bolster theory coronavirus emerged from the wild
By LAURA UNGAR
yesterday

Two new studies provide more evidence that the coronavirus pandemic originated in a Wuhan, China market where live animals were sold – further bolstering the theory that the virus emerged in the wild rather than escaping from a Chinese lab.

The research, published online Tuesday by the journal Science, shows that the Huanan Seafood Wholesale Market was likely the early epicenter of the scourge that has now killed nearly 6.4 million people around the world. Scientists conclude that the virus that causes COVID-19, SARS-CoV-2, likely spilled from animals into people two separate times.

“All this evidence tells us the same thing: It points right to this particular market in the middle of Wuhan,” said Kristian Andersen a professor in the Department of Immunology and Microbiology at Scripps Research and coauthor of one of the studies. “I was quite convinced of the lab leak myself until we dove into this very carefully and looked at it much closer.”

In one study, which incorporated data collected by Chinese scientists, University of Arizona evolutionary biologist Michael Worobey and his colleagues used mapping tools to estimate the locations of more than 150 of the earliest reported COVID-19 cases from December 2019. They also mapped cases from January and February 2020 using data from a social media app that had created a channel for people with COVID-19 to get help.

They asked, “Of all the locations that the early cases could have lived, where did they live? And it turned out when we were able to look at this, there was this extraordinary pattern where the highest density of cases was both extremely near to and very centered on this market,” Worobey said at a press briefing. “Crucially, this applies both to all cases in December and also to cases with no known link to the market … And this is an indication that the virus started spreading in people who worked at the market but then started to spread into the local community.”

Andersen said they found case clusters inside the market, too, “and that clustering is very, very specifically in the parts of the market” where they now know people were selling wildlife, such as raccoon dogs, that are susceptible to infection with the coronavirus.

In the other study, scientists analyzed the genomic diversity of the virus inside and outside of China starting with the earliest sample genomes in December 2019 and extending through mid-February 2020. They found that two lineages – A and B – marked the pandemic’s beginning in Wuhan. Study coauthor Joel Wertheim, a viral evolution expert at the University of California, San Diego, pointed out that lineage A is more genetically similar to bat coronaviruses, but lineage B appears to have begun spreading earlier in humans, particularly at the market.

“Now I realize it sounds like I just said that a once-in-a-generation event happened twice in short succession,” Wertheim said. But certain conditions were in place — such as people and animals in close proximity and a virus that can spread from animals to people and from person to person. So “barriers to spillover have been lowered such that multiple introductions, we believe, should actually be expected,” he said.

Many scientists believe the virus jumped from bats to humans, either directly or through another animal. But in June, the World Health Organization recommended a deeper probe into whether a lab accident may be to blame. Critics had said the WHO was too quick to dismiss the lab leak theory.

“Have we disproven the lab leak theory? No, we have not,” Andersen said. “But I think what’s really important here is there are possible scenarios and there are plausible scenarios and it’s really important to understand that possible does not mean equally likely.”

The pandemic’s origins remain controversial. Some scientists believe a lab leak is more likely and others remain open to both possibilities. But Matthew Aliota, a researcher in the college of veterinary medicine at the University of Minnesota, said in his mind the pair of studies “kind of puts to rest, hopefully, the lab leak hypothesis.”

“Both of these two studies really provide compelling evidence for the natural origin hypothesis,” said Aliota, who wasn’t involved in either study. Since sampling an animal that was at the market is impossible, “this is maybe as close to a smoking gun as you could get.”
 

Heliobas Disciple

TB Fanatic
(fair use applies)

The future of COVID vaccines could be sprays, not shots
Experts gathered at a summit Tuesday to talk the next generation of inoculation.
By Cheyenne Haslett
July 26, 2022, 7:01 PM

The future of COVID-19 vaccines might not be shots in the arm or leg. Instead, picture a nasal spray or a patch stuck onto the skin for a few minutes.

A group of scientists, doctors and administration health officials gathered at the White House on Tuesday to discuss the next generation of inoculation against COVID and its viral cousins; they were in agreement that there is room for improvement.

The future could include vaccines that protect equally against all variants -- or even vaccines that stop infections from happening in the first place.

"Innovative approaches are clearly needed to induce broad and durable protection against coronaviruses known and unknown," Dr. Anthony Fauci, the White House's chief medical adviser, told the audience.

There's broad consensus that despite the benefit of the currently available vaccines, the "job is not done," Fauci said.

"We've already averted well over 2 million deaths, approximately $1 trillion in health care costs and tens and tens of millions of infections, as well as close to 20 million hospitalizations. That's the good news," Fauci said. "What's the sobering news? Sobering news is why we're here today -- because our job is not done."

There are a few options on the table.

One is a pan-coronavirus vaccine, which could cover a broad array of future COVID variants and perhaps other coronaviruses, giving people protection for longer periods of time.

Another is a vaccine that people would spray into their noses, called a mucosal vaccine, or even a small patch that would be applied to the skin and carry the vaccine in microneedles.

All are promising innovations, with the potential to be combined with one another -- but all are in very early stages of development.

The "holy grail," Fauci said, is "not only to protect against disease, but to protect against acquisition, and by acquisition, transmission."

Sprays and patches

Dr. Akiko Iwasaki, an expert on nasal vaccines from Yale University who spoke at the summit, said the only way to fully achieve that goal -- Fauci's "holy grail" -- would be nasal vaccines.

She compared them to "stopping the virus from spreading right at the border," because the virus enters through the nose.
"This is akin to putting a guard outside of the house in order to patrol for invaders, compared to putting the guards in the hallway of a building in the hope they would capture the invader," Iwasaki said, contrasting the nasal vaccines to the current shots, which are injected and produce an antibody response throughout the body.

Mark Prausnitz, the chief scientific officer of Micron Biomedical, which is developing a vaccine administered through a skin patch, also pitched it as a better option to the current generation of vaccines.

"Leave it in place for a few minutes, peel it off and discard it. We think this can not only make vaccines more readily accessible, but improve immunogenicity," Prausnitz said.

He said the microneedles in the patch "are as long as a piece of paper is thick, and people barely feel them. The patches could be administered by people at home, he said, and wouldn't require inaccessible cold storage.

A summit for ideas, but also a pitch to Congress

For both the new types of vaccines on the horizon, there are still huge scientific hurdles to developing such new innovations. And without significant resources, that could take upwards of three to five years, experts estimate.

So while Tuesday's summit was a display of potential new advancements and an acknowledgement of where the current vaccines are falling behind, it was also in a pitch to lawmakers for substantial focus and investment.

"It's very important to note that we need to move quickly to start testing these nasal vaccines in humans, and that requires a significant U.S. government input, both resources and help with manufacturing and delivery as well as acceptance across society," Iwasaki told the audience.

Marty Moore, founder and chief scientific officer of another nasal vaccine company, Meissa Vaccines, said the benefits would significantly outweigh the risks.

"I think developing transmission-blocking vaccines, of course, will come with great challenges and some cost," he said. "But I think the probability of success warrants this investment based on what we know about vaccines. And the potential benefits are just enormous, direct and indirect."

White House COVID coordinator Dr. Ashish Jha has said he's hopeful the timeline for these new vaccines could be drastically reduced -- if investments are made.

But the Biden administration has faced reluctance from congressional Republicans to approve even more funding, with conservatives citing questions and objections over how past monies were spent.
 
Top